 |
|
Publications
Here you can find the articles published by the Divisions of Nuclear
Medicine and Radiopharmacy, sorted by year of publication.
Send a request for a reprint by clicking the ( )
button behind the article. For other publications by people performed
while not at the department, sent them a request
by email.
Year of Publication
| 2009 |
Phase 1 Study of the Pittsburgh Compound B Derivative 18F-Flutemetamol in Healthy Volunteers and Patients with Probable Alzheimer Disease.
Nelissen N, Van Laere K, Thurfjell L, Owenius R, Vandenbulcke M, Koole M, Bormans G, Brooks D, Vandenberghe R.
J Nucl Med (2009) in press. ()
|
Removing muscle and eye artifacts using blind source separation techniques in ictal EEG source imaging.
Hallez H, De Vos M, Vanrumste B, Van Hese P, Assecondi S, Van Laere K, Dupont P, Van Paesschen W, Van Huffel S, Lemahieu I.
Clin Neurophysiol (2009) in press. () |
18F-FDG and 18F-FLT Uptake Early After Cyclophosphamide and mTOR Inhibition in an Experimental Lymphoma Model.
Brepoels L, Stroobants S, Verhoef G, De Groot T, Mortelmans L, De Wolf-Peeters C.
J Nucl Med (2009) in press. () |
Evidence of a modality-dependent role of the cerebellum in working memory? An fMRI study comparing verbal and abstract n-back tasks.
Hautzel H, Mottaghy F, Specht K, Müller HW, Krause B.
Neuroimage (2009) in press. () |
Synthesis and biological evaluation of (11)C-labeled beta-galactosyl triazoles as potential PET tracers for in vivo LacZ reporter gene imaging.
Celen S, Cleynhens J, Deroose C, de Groot T, Ibrahimi A, Gijsbers R, Debyser Z, Mortelmans L, Verbruggen A, Bormans G.
Bioorg Med Chem (2009) in press. () |
Current and future aspects of molecular imaging.
Mottaghy F.
Methods (2009) 48(2):81-2. () |
Detection of bone metastases in patients with lung cancer: (99m)Tc-MDP planar bone scintigraphy, (18)F-fluoride PET or (18)F-FDG PET/CT.
Krüger S, Buck A, Mottaghy F, Hasenkamp E, Pauls S, Schumann C, Wibmer T, Merk T, Hombach V, Reske S.
Eur J Nucl Med Mol Imaging (2009) in press.() |
Images in neurology. Scattered cerebral microbleeds due to cardiac myxoma.
Vanacker P, Nelissen N, Van Laere K, Thijs V.
Arch Neurol (2009) 66(6):796-7. () |
Longitudinal microPET imaging of brain glucose metabolism in rat lithium-pilocarpine model of epilepsy.
Goffin K, Van Paesschen W, Dupont P, Van Laere K.
Exp Neurol (2009) 217(1):205-9. () |
Synthesis and biological evaluation of carbon-11- and fluorine-18-labeled 2-oxoquinoline derivatives for type 2 cannabinoid receptor positron emission tomography imaging.
Evens N, Muccioli G, Houbrechts N, Lambert D, Verbruggen A, Van Laere K, Bormans G.
Nucl Med Biol (2009) 36(4):455-65. () |
Highly efficient multicistronic lentivectors with peptide 2A sequences.
Ibrahimi A, Vande Velde G, Reumers V, Toelen J, Thiry I, Vandeputte C, Deroose C, Bormans G, Baekelandt V, Debyser Z, Gijsbers R, Vets S.
Hum Gene Ther (2009) in press. () |
Molecular imaging provides a hint that Miller Fisher syndrome might involve the central nervous system.
Mottaghy F.
J Neurol Neurosurg Psychiatry (2009) 80(5):467.() |
Diffusion tensor imaging in a rat model of Parkinson's disease after lesioning of the nigrostriatal tract.
Van Camp N, Blockx I, Verhoye M, Casteels C, Coun F, Leemans A, Sijbers J, Baekelandt V, Van Laere K, Van der Linden A.
NMR Biomed (2009) in press. () |
Molecular imaging of cell death.
Saint-Hubert M, Prinsen K, Mortelmans L, Verbruggen A, Mottaghy F.
Methods (2009) in press. () |
Molecular Imaging of Prostate Cancer.
Emonds K, Swinnen J, Mortelmans L, Mottaghy F.
Methods (2009) in press. () |
Small animal imaging with multi-pinhole SPECT.
Nuyts J, Vunckx K, Defrise M, Vanhove C.
Methods (2009) in press. ()
|
Biological Image-Guided Radiotherapy in Rectal Cancer: Challenges and Pitfalls.
Roels S, Slagmolen P, Nuyts J, Lee J, Loeckx D, Maes F, Vandecaveye V, Stroobants S, Ectors N, Penninckx F, Haustermans K.
Int J Radiat Oncol Biol Phys (2009) in press. () |
FDG and FLT-Uptake Early after Cyclophosphamide and mTOR-inhibition in an Experimental Lymphoma Model.
Brepoels L, Stroobants S, Verhoef G, De Groot T, Mortelmans L, De Wolf-Peeters C.
J Nucl Med (2009) in press. ()
|
Long term clinical outcome in patients with chronic pain treated with peripheral nerve stimulation.
Van Calenbergh F, Gybels J, Van Laere K, Dupont P, Plaghki L, Depreitere B, Kupers R.
Surgical Neurology (2009) in press. ()
|
11C-labelled PIB analogues as potential tracer agents for in vivo imaging of amyloid beta in Alzheimer's disease.
Serdons K, Verduyckt T, Vanderghinste D, Borghgraef P, Cleynhens J, Van Leuven F, Kung H, Bormans G, Verbruggen A.
Eur J Med Chem (2009) 44(4):1415-26.()
|
Method of bioluminescence imaging for molecular imaging of physiological and pathological processes.
Gheysens O, Mottaghy F.
Methods (2009) in press. () |
Developing new molecular imaging probes for PET.
Serdons K, Verbruggen A, Bormans G.
Methods (2009) in press.() |
Cortical deactivations during gastric fundus distension in health: visceral pain-specific response or attenuation of 'default mode' brain function? A H2 15O-PET study.
van Oudenhove L, Vandenberghe J, Dupont P, Geeraerts B, Vos R, Bormans G, van Laere K, Fischler B, Demyttenaere K, Janssens J, Tack J.
Neurogastroenterol Motil (2009) 21(3):259-71.()
|
Diagnostic evaluation of PSA recurrence and review of hormonal management after radical prostatectomy.
Van Poppel H, Joniau S, Van Cleynenbreugel B, Mottaghy F, Oyen R.
Prostate Cancer Prostatic Dis (2009) in press.()
|
[(11)C]choline PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy.
Rinnab L, Simon J, Hautmann R, Cronauer M, Hohl K, Buck A, Reske S, Mottaghy F.
World J Urol (2009) in press.()
|
Whole body biodistribution and radiation dosimetry of 18F‐GE067, a radioligand for in vivo brain amyloid imaging.
Koole M, Lewis D, Buckley C, Nelissen N, Vandenbulcke M, Brooks D, Vandenberghe R, Van Laere K.
J Nucl Med (2009) 50(5):818-822.()
|
Synthesis and Evaluation of (18)F-Labeled 2-Phenylbenzothiazoles as Positron Emission Tomography Imaging Agents for Amyloid Plaques in Alzheimer's Disease.
Serdons K, Terwinghe C, Vermaelen P, Van Laere K, Kung H, Mortelmans L, Bormans G, Verbruggen.
A.J Med Chem (2009) in press.() |
Relationship
of Type 1 Cannabinoid Receptor Availability in the Human Brain to
Novelty-Seeking Temperament.
Van Laere K, Goffin K, Bormans G, Casteels C, Mortelmans L, de Hoon
J, Grachev I, Vandenbulcke M, Pieters G.
Arch Gen Psychiatry (2009) 66(2):196-204.() |
Synthesis
of 18F-labelled 2-(40-fluorophenyl)-1,3-benzothiazole and evaluation
as amyloid imaging agent in comparison with [11C]PIB.
Serdons K, Verduyckt T, Vanderghinste D, Cleynhens J, Borghgraef
P, Vermaelen P, Terwinghe C, Van Leuven F, Van Laere K, Kung H,
Bormans G, Verbruggen A.
Bioorg Med Chem Lett (2009) 19(3):602-5.()
|
[18F]EF3 is not superior to [18F]FMISO for PET-based hypoxia evaluation as measured in a rat rhabdomyosarcoma tumour model.
Dubois L, Landuyt W, Cloetens L, Bol A, Bormans G, Haustermans K, Labar D, Nuyts J, Grégoire V, Mortelmans L.
Eur J Nucl Med Mol Imaging (2009) 36(2):209-18.()
|
Neurodegenerative parkinsonism and progressive external ophthalmoplegia with a Twinkle mutation.
Vandenberghe W, Van Laere K, Debruyne F, Van Broeckhoven C, Van Goethem G.
Mov Disord (2009) 24(2):308-9.() |
In vivo bioluminescence imaging in an experimental mouse model for dendritic cell based immunotherapy against malignant glioma.
Maes W, Deroose C, Reumers V, Krylyshkina O, Gijsbers R, Baekelandt V, Ceuppens J, Debyser Z, Van Gool S.
J Neurooncol (2009) 91(2):127-39.() |
Suppression of metal artifacts in CT using a reconstruction procedure that combines MAP and projection completion.
Lemmens C, Faul D, Nuyts J.
IEEE Trans Med Imaging (2009) 28(2):250-60.() |
Performance of MAP reconstruction for hot lesion detection in whole-body PET/CT: an evaluation with human and numerical observers.
Nuyts J, Michel C, Brepoels L, De Ceuninck L, Deroose C, Goffin K, Mottaghy F, Stroobants S, Riet J, Verscuren R.
IEEE Trans Med Imaging (2009) 28(1):67-73.()
|
Ga-68 DOTATOC PET/CT changed the therapeutic course of a patient with the sudden onset of vision problems.
Van Riet J, Rattat D, Verbruggen A, Mortelmans L, Mottaghy F.
Clin Nucl Med (2009) 34(1):27-8.() |
Disparity Between In Vivo EGFR Expression and 89Zr-Labeled Cetuximab Uptake Assessed with PET.
Aerts H, Dubois L, Perk L, Vermaelen P, van Dongen G, Wouters B, Lambin P.
J Nucl Med (2009) 50(1):123-131.() |
Detection of inter-hemispheric metabolic asymmetries in FDG-PET images using prior anatomical information.
Zhou L, Dupont P, Baete K, Van Paesschen W, Van Laere K, Nuyts J.
Neuroimage (2009) 44(1):35-42.() |
TOP
Cortical deactivations during gastric fundus distension in health: visceral pain-specific
response or attenuation of 'default mode' brain function? A H(2)(15)O-PET study.
Van Oudenhove L, Vandenberghe J, Dupont P, Geeraerts B, Vos R, Bormans G, van Laere K, Fischler B, Demyttenaere K, Janssens J, Tack J.
Neurogastroenterol Motil (2008) in press.() |
(11)C-labelled PIB analogues as potential tracer agents for in vivo imaging of amyloid beta in Alzheimer's disease.
Serdons K, Verduyckt T, Vanderghinste D, Borghgraef P, Cleynhens J, Van Leuven F, Kung H, Bormans G, Verbruggen A.
Eur J Med Chem (2008) in press.() |
Value of positron emission tomography of the para-aortic lymph nodes in cervical carcinoma stage IB2-IIIB.
Vergote I, Tsolakidis D, Mortier D, Neven P, Amant F, Mottaghy F, Van Limbergen E.
J Clin Oncol (2008) 26(34):5654-5.() |
The presence of ethanol in radiopharmaceutical injections.
Serdons K, Verbruggen A, Bormans G.
J Nucl Med (2008) 49(12):2071.() |
First demonstration of leukemia imaging with the proliferation marker 18F-fluorodeoxythymidine.
Buck A, Bommer M, Juweid M, Glatting G, Stilgenbauer S, Mottaghy F, Schulz M, Kull T, Bunjes D, Möller P, Döhner H, Reske S.
J Nucl Med (2008) 49(11):1756-62.() |
Guideline to regulations for radiopharmaceuticals in early phase clinical trials in the EU.
Verbruggen A, Coenen H, Deverre J, Guilloteau D, Langstrom B, Salvadori P, Halldin C.
Eur J Nucl Med Mol Imaging (2008) 35(11):2144-51.() |
Evaluation of lung tumor perfusion by dynamic contrast-enhanced MRI.
Pauls S, Mottaghy F, Schmidt S, Krüger S, Möller P, Brambs H, Wunderlich A.
Magn Reson Imaging (2008) 26(10):1334-41.() |
Noninvasive and quantitative monitoring of adult neuronal stem cell migration in mouse brain using bioluminescence imaging.
Reumers V, Deroose C, Krylyshkina O, Nuyts J, Geraerts M, Mortelmans L, Gijsbers R, Van den Haute C, Debyser Z, Baekelandt V.
Stem Cells (2008) 26(9):2382-90.() |
Positron emission tomography in mantle cell lymphoma.
Brepoels L, Stroobants S, De Wever W, Dierickx D, Vandenberghe P, Thomas J, Mortelmans L, Verhoef G, De Wolf-Peeters C.
Leuk Lymphoma (2008) 49(9):1693-701.() |
A specific blend of intact protein rich in aspartate has strong postprandial glucose attenuating properties in rats.
Hageman R, Severijnen C, van de Heijning B, Bouritius H, van Wijk N, van Laere K, van der Beek E.
J Nutr (2008) 138(9):1634-40.() |
Thalamic and limbic involvement in the mechanism of action of vagus nerve stimulation, a SPECT study.
Vonck K, De Herdt V, Bosman T, Dedeurwaerdere S, Van Laere K, Boon P.
Seizure (2008) 17(8):699-706.() |
Impact of metal artefacts due to EEG electrodes in brain PET/CT imaging.
Lemmens C, Montandon M, Nuyts J, Ratib O, Dupont P, Zaidi H.
Phys Med Biol (2008) 53(16):4417-29.() |
An in vivo [18F]MK-9470 microPET study of type 1 cannabinoid receptor binding in Wistar rats after chronic administration of valproate and levetiracetam.
Goffin K, Bormans G, Casteels C, Bosier B, Lambert D, Grachev I, Van Paesschen W, Van Laere K.
Neuropharmacology (2008) 54(7):1103-6.() |
The cost effectiveness of 123I-FP-CIT SPECT imaging in patients with an uncertain clinical diagnosis of parkinsonism.
Van Laere K, Everaert L, Annemans L, Gonce M, Vandenberghe W, Vander Borght T.
Eur J Nucl Med Mol Imaging (2008) 35(7):1367-76.() |
Labelling and biological evaluation of [(11)C]methoxy-Sch225336: a radioligand for the cannabinoid-type 2 receptor.
Evens N, Bosier B, Lavey B, Kozlowski J, Vermaelen P, Baudemprez L, Busson R, Lambert D, Van Laere K, Verbruggen A, Bormans G.
Nucl Med Biol (2008) 35(7):793-800.() |
Effect of overlapping projections on reconstruction image quality in multipinhole SPECT.
Vunckx K, Suetens P, Nuyts J.
IEEE Trans Med Imaging (2008) 27(7):972-83.() |
Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1.
Suls A, Dedeken P, Goffin K, Van Esch H, Dupont P, Cassiman D, Kempfle J, Wuttke T, Weber Y, Lerche H, Afawi Z, Vandenberghe W, Korczyn A, Berkovic S, Ekstein D, Kivity S, Ryvlin P, Claes L, Deprez L, Maljevic S, Vargas A, Van Dyck T, Goossens D, Del-Favero J, Van Laere K, De Jonghe P, Van Paesschen W.
Brain (2008) 131(7)1831-44.() |
Preliminary in vivo evaluation of a novel 99mTc-labeled HYNIC-cys-annexin A5 as an apoptosis imaging agent.
Fonge H, de Saint Hubert M, Vunckx K, Rattat D, Nuyts J, Bormans G, Ni Y, Reutelingsperger C, Verbruggen A.
Bioorg Med Chem Lett (2008) 18(13):3794-8.() |
Non-Hodgkin lymphoma: retrospective study on the cost-effectiveness of early treatment response assessment by FDG-PET.
Moulin-Romsee G, Spaepen K, Stroobants S, Mortelmans L.
Eur J Nucl Med Mol Imaging (2008) 35(6):1074-80.() |
GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leak.
Weber Y, Storch A, Wuttke T, Brockmann K, Kempfle J, Maljevic S, Margari L, Kamm C, Schneider S, Huber S, Pekrun A, Roebling R, Seebohm G, Koka S, Lang C, Kraft E, Blazevic D, Salvo-Vargas A, Fauler M, Mottaghy F, Münchau A, Edwards M, Presicci A, Margari F, Gasser T, Lang F, Bhatia K, Lehmann-Horn F, Lerche H.
J Clin Invest (2008) 118(6):2157-68.() |
The role of somatosensory cortical regions in the processing of painful gastric fundic distension: an update of brain imaging findings.
Van Oudenhove L, Dupont P, Vandenberghe J, Geeraerts B, van Laere K, Bormans G, Demyttenaere K, Tack J.
Neurogastroenterol Motil (2008) 20(5):479-87.() |
Noninvasive brain stimulation with transcranial magnetic or direct current stimulation (TMS/tDCS)-From insights into human memory to therapy of its dysfunction.
Sparing R, Mottaghy F.
Methods (2008) 44(4):329-37.() |
Models in memory research.
Mottaghy F.
Methods (2008) 44(4):287-8.() |
Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [(18)F]MK-9470 PET.
Van Laere K, Goffin K, Casteels C, Dupont P, Mortelmans L, de Hoon J, Bormans G.
Neuroimage (2008) 39(4):1533-41.() |
Neuronuclear assessment of patients with epilepsy.
Goffin K, Dedeurwaerdere S, Van Laere K, Van Paesschen W.
Semin Nucl Med (2008) 38(4):227-39.() |
Use of integrated FDG-PET/CT in sarcoidosis.
Krüger S, Buck A, Mottaghy F, Pauls S, Schelzig H, Hombach V, Reske S.
Clin Imaging (2008) 32(4):269-73.() |
Whole-body Biodistribution and Radiation
Dosimetry of the Human
Cannabinoid-Type 1 Receptor Ligand 18F-MK-9470 in Healthy Subjects.
Van Laere K, Koole M, Sanabria-Bohorquez S, Goffin K, Guenther
I, Belanger M, Cote J, Rothernberg P, De Lepeleire I, Grachev I,
Hargreaves R, Bormans G, Burns H.
J Nucl Med (2008) 49(3):439-45.() |
Dopaminergic dysfunction in attention deficit hyperactivity disorder (ADHD), differences between pharmacologically treated and never treated young adults: a 3,4-dihdroxy-6-[18F]fluorophenyl-l-alanine PET study.
Ludolph A, Kassubek J, Schmeck K, Glaser C, Wunderlich A, Buck A, Reske S, Fegert J, Mottaghy F.
Neuroimage (2008) 41(3):718-27.() |
[11C]Choline PET/CT for targeted salvage lymph node dissection in patients with biochemical recurrence after primary curative therapy for prostate cancer. Preliminary results of a prospective study.
Rinnab L, Mottaghy F, Simon J, Volkmer B, de Petriconi R, Hautmann R, Wittbrodt M, Egghart G, Moeller P, Blumstein N, Reske S, Kuefer R.
Urol Int (2008) 81(2):191-7.() |
Variability of BOLD response evoked by foot vibrotactile stimulation: influence of vibration amplitude and stimulus waveform.
Siedentopf C, Heubach K, Ischebeck A, Gallasch E, Fend M, Mottaghy F, Koppelstaetter F, Haala I, Krause B, Felber S, Gerstenbrand F, Golaszewski S.
Neuroimage (2008) 41(2):504-10.() |
Performance of integrated FDG-PET/CT for differentiating benign and malignant lung lesions--results from a large prospective clinical trial.
Pauls S, Buck A, Halter G, Mottaghy F, Muche R, Bluemel C, Gerstner S, Krüger S, Glatting G, Sunder-Plassmann L, Möller P, Brambs H, Reske S.
Mol Imaging Biol (2008) 10(2):121-8.() |
Synthesis and evaluation of 18F- and 11C-labeled phenyl-galactopyranosides as potential probes for in vivo visualization of LacZ gene expression using positron emission tomography.
Celen S, Deroose C, de Groot T, Chitneni S, Gijsbers R, Debyser Z, Mortelmans L, Verbruggen A, Bormans G.
Bioconjug Chem (2008) 19(2):441-9.() |
Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism.
Aragonés J, Schneider M, Van Geyte K, Fraisl P, Dresselaers T, Mazzone M, Dirkx R, Zacchigna S, Lemieux H, Jeoung N, Lambrechts D, Bishop T, Lafuste P, Diez-Juan A, Harten S, Van Noten P, De Bock K, Willam C, Tjwa M, Grosfeld A, Navet R, Moons L, Vandendriessche T, Deroose C, Wijeyekoon B, Nuyts J, Jordan B, Silasi-Mansat R, Lupu F, Dewerchin M, Pugh C, Salmon P, Mortelmans L, Gallez B, Gorus F, Buyse J, Sluse F, Harris R, Gnaiger E, Hespel P, Van Hecke P, Schuit F, Van Veldhoven P, Ratcliffe P, Baes M, Maxwell P, Carmeliet P.
Nat Genet (2008) 40(2):170-80.() |
In vivo characterization and dynamic receptor occupancy imaging of TPA023B, an alpha 2/alpha 3/alpha 5 subtype selective gamma-aminobutyric acid-a partial agonist.
Van Laere K, Bormans G, Sanabria-Bohórquez S, de Groot T, Dupont P, De Lepeleire I, de Hoon J, Mortelmans L, Hargreaves R, Atack J, Burns H.
Biol Psychiatry (2008) 64(2):153-61.() |
Non-invasive detection and quantification
of acute myocardial infarction in rabbits using mono-[123I]iodohypericin
microSPECT.
Fonge H, Vunckx K, Wang H, Feng Y, Mortelmans L, Nuyts J, Bormans
G, Verbruggen A, Ni Y.
Eur Heart J (2008) 29(2):260-9.() |
Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [(18)F]MK-9470 PET.
Van Laere K, Goffin K, Casteels C, Dupont P, Mortelmans L, de Hoon
J, Bormans G.
NeuroImage (2008) 39(4):1533-41.() |
Bone scintigraphy in electrocution wounds and comparison with FDG-PET images.
Van Riet J, Mortelmans L.
Eur J Nucl Med Mol Imaging (2008) 35(2):448.() |
Efficient purification and metabolite analysis of radiotracers using high-performance liquid chromatography and on-line solid-phase extraction.
Chitneni S, Serdons K, Evens N, Fonge H, Celen S, Deroose C, Debyser Z, Mortelmans L, Verbruggen A, Bormans G.
J Chromatogr A (2008) 1189(1-2):323-31.() |
Metabolic-dopaminergic mapping of the 6-hydroxydopamine rat model for Parkinson's disease.
Casteels C, Lauwers E, Bormans G, Baekelandt V, Van Laere K.
Eur J Nucl Med Mol Imaging (2008) 35(1):124-34.() |
Improved synthesis and metabolic
stability analysis of the dopamine transporter ligand [(18)F]FECT.
Chitneni S, Garreau L, Cleynhens B, Evens N, Bex M, Vermaelen P,
Chalon S, Busson R, Guilloteau D, Van Laere K, Verbruggen A, Bormans
G.
Nucl Med Biol (2008) 35(1):75-82.()
|
The CB1R Inverse Agonist Taranabant
Mediates Weight Loss by Increasing Energy Expenditure and Decreasing
Caloric Intake.
Addy C, Wright H, Van Laere K, Gantz I, Erondu N, Musser B, Lu K
Yuan J, Sanabria-Bohorquez S, Stoch A, Stevens C, De Lepeleire I,
Cilissen C, Cote J, Rosko K, Gendrano N, Nguyen A, Gumbiner B,
Rothenberg P, Ravussin E, Klein S, Blundell J, de Hoon J, Bormans
G, Van Hecken A, Burns D, Hargreaves R, Wagner J, Gottesdiener
K, Herman G, Amatruda J, Heymsfield S.
Cell Metabolism (2008) 7(1):68-78.() |
Molecular imaging of reporter gene expression in prostate cancer: an overview.
Singh A, Massoud T, Deroose C, Gambhir S.
Semin Nucl Med (2008) 38(1):9-19.() |
In vivo microPET
imaging of metabolism and dopamine transporters in the 6OHDA model
of Parkinson’s disease.
Casteels C, Goffin K, Bormans G, Baekelandt V, Van Laere K.
Eur J Nucl Med Molec Imaging (2007) 35(1):124-134.() |
Single and multipinhole collimator design evaluation method for small animal SPECT.
Vunckx K, Beque D, Defrise M, Nuyts J.
IEEE Trans Med Imaging (2008) 27(1):36-46.() |
Development of radioligands for in vivo imaging of type 1 cannabinoid receptors (CB1) in human brain.
Horti A, Van Laere K.
Curr Pharm Des (2008) 14(31):3363-83.() |
TOP
[18F]MK-9470, a positron emission
tomography (PET) tracer for in vivo human PET brain imaging of the
cannabinoid-1 receptor.
Burns H, Van Laere K, Sanabria-Bohorquez S, Hamill T,
Bormans G, Eng W, Gibson R, Ryan C, Connolly B, Patel S, Krause
S, Vanko A, Van Hecken A, Dupont P, De Lepeleire I, Rothenberg P,
Stoch S, Cote J, Hagmann W, Jewell J, Lin L, Liu P, Goulet M,
Gottesdiener K, Wagner J, de Hoon J, Mortelmans L, Fong T, Hargreaves
R.
Proc Natl Acad Sci USA (2007) 104(23):9800-9805.() |
Visualizing out-of-body experience
in the brain.
De Ridder D, Van Laere K, Dupont P, Menosvky T, Van de Heyning
P.
New Engl J Med (2007) 357(18):1829-33.() |
Synthesis and preliminary evaluation
of mono-[(123)I]iodohypericin monocarboxylic acid as a necrosis
avid imaging agent.
Fonge H, Jin L, Wang H, Ni Y, Bormans G, Verbruggen A.
Bioorg Med Chem Lett (2007) 17(14):4001-5.()
|
Non-invasive grading of brain tumours
using dynamic amino acid PET imaging : does it work for 11C-Methionine?
Moulin-Romsee G, D'Hondt E, de Groot T, Goffin J, Sciot R,
Mortelmans L, Menten J, Bormans G, Van Laere K.
Eur J Nucl Med Mol Imaging (2007) 34(12):2082-7.() |
Synthesis and biological evaluation
of an (123)I-labeled bicyclic nucleoside analogue (BCNA) as potential
SPECT tracer for VZV-tk reporter gene imaging.
Chitneni S, Deroose C, Fonge H, Gijsbers R, Dyubankova
N, Balzarini J, Debyser Z, Mortelmans L, Verbruggen A, Bormans
G.
Bioorg Med Chem Lett (2007) 17(12):3458-62.() |
In vivo imaging of the endocannabinoid
system : a novel window to a central modulatory mechanism in humans.
Van Laere K.
Eur J Nucl Med Molec Imag (2007) 34(11):1719-26.() |
Sparing of the substantia nigra
in Creutzfeldt-Jakob disease presenting as an acute corticobasal
syndrome.
Vandenberghe W, Sciot R, Demaerel P, Van Laere K.
Mov Disord (2007) 22(11):1668-9.() |
Cognitive deficits during status epilepticus
and time course of recovery: a case report.
Van Paesschen W, Porke K, Fannes K, Vandenberghe R, Palmini A, Van
Laere K, Dupont P.
Epilepsia (2007) 48(10):1979-83.() |
The maximum uptake of (18)F-deoxyglucose
on positron emission tomography scan correlates with survival, hypoxia
inducible factor-1alpha and GLUT-1 in non-small cell lung cancer.
van Baardwijk A, Dooms C, van Suylen R, Verbeken E, Hochstenbag
M, Dehing-Oberije C, Rupa D, Pastorekova S, Stroobants S, Buell
U, Lambin P, Vansteenkiste J, Ruysscher D.
Eur J Cancer (2007) 43(9):1392-8.()
|
Amyloid deposition in the language
system in early-stage probable Alzheimer’s disease.
Nelissen N, Vandenbulcke M, Fannes K, Verbruggen A, Peeters
R, Dupont P, Van Laere K, Bormans G, Vandenberghe R.
Brain (2007) 130(8):2055-69.() |
Atrial metastasis of esophageal
carcinoma detected by follow-up FDG PET/CT.
Moulin-Romsee G, De Wever W, Verbeken E, Mortelmans L.
Clin Nucl Med (2007) 32(5):393-5.() |
Regional cerebral blood flow during
gastric balloon distention in functional dyspepsia.
Vandenberghe J, Dupont P, Van Oudenhove L, Bormans G,
Demyttenaere K, Fischler B, Geeraerts B, Janssens J, Tack J.
Gastroenterology (2007) 132(5):1684-93.() |
Improving the Interpretation of
Ictal Scalp EEG: BSS-CCA Algorithm for Muscle Artifact Removal.
Vergult A, De Clercq W, Palmini A, Vanrumste B, Dupont
P, Van Huffel S, Van Paesschen W.
Epilepsia (2007) 48(5):950-8.() |
Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer.
De Wever W, Vankan Y, Stroobants S, Verschakelen J.
Eur Respir J (2007) 29(5):995-1002.() |
Synthesis and preliminary evaluation
of 18F- or 11C-labeled bicyclic nucleoside analogues as potential
probes for imaging varicella-zoster virus thymidine kinase gene
expression using positron emission tomography.
Chitneni SK, Deroose CM, Balzarini J, Gijsbers R, Celen
SJ, de Groot TJ, Debyser Z, Mortelmans L, Verbruggen AM, Bormans
GM.
J Med Chem (2007) 50(5):1041-9.() |
Use of positron emission tomography
for response assessment of lymphoma: consensus of the Imaging Subcommittee
of International Harmonization Project in Lymphoma.
Juweid ME, Stroobants S, Hoekstra OS, Mottaghy FM, Dietlein
M, Guermazi A, Wiseman GA, Kostakoglu L, Scheidhauer K, Buck A, Naumann
R, Spaepen K, Hicks RJ, Weber WA, Reske SN, Schwaiger M, Schwartz
LH, Zijlstra JM, Siegel BA, Cheson BD; Imaging Subcommittee of International
Harmonization Project in Lymphoma.
J Clin Oncol (2007) 25(5):571-8.() |
Revised response criteria for malignant
lymphoma.
Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L,
Horning SJ, Coiffier B, Fisher RI, Hagenbeek A, Zucca E, Rosen ST,
Stroobants S, Lister TA, Hoppe RT, Dreyling M, Tobinai K, Vose JM,
Connors JM, Federico M, Diehl V; The International Harmonization Project
on Lymphoma.
J Clin Oncol (2007) 25(5):579-86.() |
Dynamic scintigraphy suggested
renal malrotation in a patient with a kidney mass on ultrasound.
Verscuren R, Mortelmans L.
Clin Nucl Med (2007) 32(4):323-4.() |
Quantification of Parkinson's disease-related
network expression with ECD SPECT.
Eckert T, Van Laere K, Tang C, Lewis D, Edwards C, Santens
P, Eidelberg D.
Eur J Nucl Med Mol Imaging (2007) 34(4):496-501.() |
Fetal gene transfer with lentiviral
vectors: long-term in vivo follow-up evaluation in a rat model.
Toelen J, Deroose C, Gijsbers R, Reumers V, Sbragia L,
Vets S, Chitneni S, Bormans G, Mortelmans L, Deprest J, Debyser
Z.
Am J Obstet Gynecol (2007) 196(4):352.() |
Evaluation of tumor affinity of
mono-[(123)I]iodohypericin and mono-[(123)I]iodoprotohypericin in
a mouse model with a RIF-1 tumor.
Fonge H, Van de Putte M, Huyghe D, Bormans G, Ni Y, de
Witte P, Verbruggen A.
Contrast Media Mol Imaging (2007) 2(3):113-9.() |
Synthesis and evaluation of a (99m)Tc-MAMA-propyl-thymidine
complex as a potential probe for in vivo visualization of tumor
cell proliferation with SPECT.
Celen S, de Groot T, Balzarini J, Vunckx K, Terwinghe C,
Vermaelen P, Van Berckelaer L, Vanbilloen H, Nuyts J, Mortelmans
L, Verbruggen A, Bormans G.
Nucl Med Biol (2007) 34(3):283-91.() |
Comparative analysis of adeno-associated
viral vector serotypes 1, 2, 5, 7, and 8 in mouse brain.
Taymans JM, Vandenberghe LH, Haute CV, Thiry I, Deroose
CM, Mortelmans L, Wilson JM, Debyser Z, Baekelandt V.
Hum Gene Ther (2007) 18(3):195-206.() |
Effect of corticosteroids on 18F-FDG
uptake in tumor lesions after chemotherapy.
Brepoels L, Stroobants S, Vandenberghe P, Spaepen K, Dupont
P, Nuyts J, Bormans G, Mortelmans L, Verhoef G, De Wolf-Peeters
C.
J Nucl Med (2007) 48(3):390-7.() |
Cyclicity of spontaneous recurrent seizures in pilocarpine model of temporal lobe epilepsy in rat.
Goffin K, Nissinen J, Van Laere K, Pitkänen A.
Experimental Neurology (2007) 205(2):501-5.() |
The use of SPECT and PET in routine
clinical practice in epilepsy.
Van Paesschen W, Dupont P, Sunaert S, Goffin K, Van Laere K.
Curr Opin Neurol (2007) 20(2):194-202.() |
Additional value of integrated PET-CT
in the detection and characterization of lung metastases: correlation
with CT alone and PET alone.
De Wever W, Meylaerts L, De Ceuninck L, Stroobants S, Verschakelen
JA.
Eur Radiol (2007) 17(2):467-73.() |
PET and PET/CT for response evaluation
in lymphoma: current practice and developments.
Brepoels L, Stroobants S, Verhoef G.
Leuk Lymphoma (2007) 48(2):270-82.() |
Reduced Force Generating Capacity
in Myocytes From Chronically Ischemic, Hibernating Myocardium.
Bito V, van der Velden J, Claus P, Dommke C, Van Lommel
A, Mortelmans L, Verbeken E, Bijnens B, Stienen G, Sipido KR.
Circ Res (2007) 100(2):229-37.() |
Resolution recovery in pinhole
SPECT based on multi-ray projections: a phantom study.
Vanhove C, Andreyev A, Defrise M, Nuyts J, Bossuyt A
Eur J Nucl Med Mol Imaging (2007) 34(2):170-80.() |
Motor- and food-related metabolic
cerebral changes in the activity-based rat model for anorexia nervosa
: a voxel-based microPET study.
Van Kuyck K, Casteels C, Vermaelen P, Bormans G, Nuttin
B , Van Laere K.
Neuroimage (2007) 35(1):214-221.() |
TOP
Prospective comparative study of integrated
PET scan compared with remediastinoscopy in the assessment of residual
mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven
stage IIIA-N2 Non-small-cell lung cancer: a Leuven Lung Cancer Group
Study.
De Leyn P, Stroobants S, De Wever W, Lerut T, Coosemans W,
Decker G, Nafteux P, Van Raemdonck D, Mortelmans L, Nackaerts K, Vansteenkiste
J.
J Clin Oncol (2006) 24(21):3333-9.() |
Construction and Evaluation of
Multitracer Small-Animal PET Probabilistic Atlases for Voxel-Based
Functional Mapping of the Rat Brain.
Casteels C, Vermaelen P, Nuyts J, Van Der Linden A, Baekelandt
V, Mortelmans L, Bormans G, Van Laere K.
J Nucl Med (2006) 47(11):1858-1866.() |
EANM Procedure Guideline for Brain
Tumour Imaging using Labelled Amino Acid Analogues.
Vander Borght T, Asenbaum S, Bartenstein P, Halldin C,
Kapucu O, Van Laere K, Varrone A, Tatsch K.
Eur J Nucl Med Molec Imag (2006) 33(11):1374-80.() |
The influence of attenuation correction
and reconstruction techniques on the detection of hypo-perfused
lesions in brain SPECT images.
Ghoorun S, Baete K, Nuyts J, Groenewald W, Dupont P.
Nucl Med Commun (2006) 27(10):765-72.() |
Ictal Perfusion Patterns Associated
with Single MRI-Visible Focal Dysplastic Lesions: Implications for
the Noninvasive Delineation of the Epileptogenic Zone.
Dupont P, Van Paesschen W, Palmini A, Ambayi R, Van Loon
J, Goffin J, Weckhuysen S, Sunaert S, Thomas B, Demaerel P, Sciot
R, Becker AJ, Vanbilloen H, Mortelmans L, Van Laere K.
Epilepsia (2006) 47(9):1550-7.() |
Alzheimer dementia caused by a novel
mutation located in the APP C-terminal intracytosolic fragment.
Theuns J, Marjaux E, Vandenbulcke M, Van Laere K, Bormans
G, Kumar-Singh S, Van den Broeck M, Vennekens K, Corsmit E, De Strooper
B, Van Broeckhoven C, Vandenberghe R.
Human Mutation (2006) 27(9):888-896.() |
11C-methionine PET, histopathology
and survival in primary brain tumours and recurrence.
Ceyssens S, Van Laere K, de Groot T, Goffin J, Bormans
G, Mortelmans L.
Am J Neuroradiol (2006) 27(7):1432-1437.() |
Age and gender effects on normal regional
cerebral blood flow.
Pirson AS, Vander Borght T, Van Laere K, Takahashi K, Yamaguchi
S.
Am J Neuroradiol (2006) 27(6):1161-3.() |
Metabolic imaging of anterior capsular
stimulation in refractory obsessive-compulsive disorder: a key role
for the subgenual anterior cingulate and ventral striatum.
Van Laere K, Nuttin B, Gabriels L, Dupont P, Rasmussen S, Greenberg
BD, Cosyns P.
J Nucl Med (2006) 47(5):740-7.() |
First preclinical evaluation of
mono-[(123)I]iodohypericin as a necrosis-avid tracer agent.
Ni Y, Huyghe D, Verbeke K, de Witte PA, Nuyts J, Mortelmans L, Chen
F, Marchal G, Verbruggen AM, Bormans GM.
Eur J Nucl Med Mol Imaging (2006) 33(5):595-601.() |
Repetitive 18-fluorodeoxyglucose
positron emission tomography in isolated polymyalgia rheumatica:
a prospective study in 35 patients.
Blockmans D, De Ceuninck L, Vanderschueren S, Knockaert
D, Mortelmans L, Bobbaers H.
Rheumatology (Oxford) (2006) 46(4):672-7.() |
The current status of FDG-PET in tumour
volume definition in radiotherapy treatment planning.
van Baardwijk A, Baumert BG, Bosmans G, van Kroonenburgh M, Stroobants
S, Gregoire V, Lambin P, De Ruysscher D.
Cancer Treat Rev (2006) 32(4):245-60.() |
Word Reading and Posterior Temporal
Dysfunction in Amnestic Mild Cognitive Impairment.
Vandenbulcke M, Peeters R, Dupont P, Van Hecke P, Vandenberghe R.
Cereb Cortex (2006) 17(3):542-51.() |
Evaluation of (99m)Tc-labeled tropanes
with alkyl substituents on the 3beta-phenyl ring as potential dopamine
transporter tracers.
Vanbilloen HP, Kieffer DM, Cleynhens BJ, Bormans GM, Mortelmans L,
Verbruggen AM.
Nucl Med Biol (2006) 33(3):413-8.() |
Dual-tracer dopamine transporter and
perfusion SPECT imaging in early differential diagnosis of parkinsonism
using template-based discriminant analysis.
Van Laere K, Casteels C, De Ceuninck L, Maes A, Vanbilloen B, Mortelmans
L, Vandenberghe W, Verbruggen A, Dom R.
J Nucl Med (2006) 47(3):384-92.() |
Lhermitte-Duclos disease: (11)C-methionine
positron emission tomography data in 4 patients.
Van Calenbergh F, Vantomme N, Flamen P, Demaerel P, Sciot R, Legius
E, Mortelmans L, Plets C.
Surg Neurol (2006) 65(3):293-296.() |
The impact of aggregation on the
biodistribution of hypericin.
Van De Putte M, Roskams T, Bormans G, Verbruggen A, De Witte PA.
Int J Oncol (2006) 28(3):655-60.() |
Noninvasive Monitoring of Long-Term
Lentiviral Vector-Mediated Gene Expression in Rodent Brain with Bioluminescence
Imaging.
Deroose CM, Reumers V, Gijsbers R, Bormans G, Debyser Z,
Mortelmans L, Baekelandt V.
Mol Ther (2006) 14(3):423-31.() |
Correlations of interictal FDG-PET
metabolism and ictal SPECT perfusion changes in human temporal lobe
epilepsy with hippocampal sclerosis.
Nelissen N, Van Paesschen W, Baete K, Van Laere K, Palmini
A, Van Billoen H, Dupont P.
Neuroimage (2006) 32(2):684-695.() |
Establishment of a mouse gastrointestinal
stromal tumour model and evaluation of response to imatinib by small
animal positron emission tomography.
Prenen H, Deroose C, Vermaelen P, Sciot R, Debiec-Rychter M, Stroobants
S, Mortelmans L, Schoffski P, Van Oosterom A.
Anticancer Res (2006) 26(2A):1247-52.() |
CMR 2005: 3.02: The stromal mechanism:
an inherent link between necrosis-avid contrast agents and photodynamic
therapy.
Ni Y, Chen F, Bormans G, Verbruggen A, Marchal G.
Contrast Media Mol Imaging (2006) 1(2):57-8.() |
Non-invasive imaging of neuropathology
in a rat model of alpha-synuclein overexpression.
Lauwers E, Beque D, Van Laere K, Nuyts J, Bormans G, Mortelmans
L, Casteels C, Vercammen L, Bockstael O, Nuttin B, Debyser Z, Baekelandt
V.
Neurobiol Aging (2007) 28(2):248-57.() |
Synthesis and biological evaluation
of a technetium-99m(I)-tricarbonyl-labelled phenyltropane derivative.
Kieffer DM, Cleynhens BJ, Vanbilloen HP, Rattat D, Terwinghe CY,
Mortelmans L, Bormans GM, Verbruggen AM.
Bioorg Med Chem Lett (2006) 16(2):382-6.() |
The effect of a methyl or 2-fluoroethyl
substituent at the N-3 position of thymidine, 3’-fluoro-3’-deoxythymidine
(FLT) and 1-ß-D-arabinosylthymine (ara-T) on their antiviral
and cytostatic activity in cell culture.
Balzarini J, Celen S, Karlsson A, de Groot T, Verbruggen
A, Bormans G.
Antiviral Chem.Chemother (2006) 17(1):17-23.() |
Recombinant P-selectin glycoprotein
ligand-immunoglobulin, a P-selectin antagonist, as an adjunct to thrombolysis
in acute myocardial infarction. The P-Selectin Antagonist Limiting
Myonecrosis (PSALM) trial.
Mertens P, Maes A, Nuyts J, Belmans A, Desmet W, Esplugas
E, Charlier F, Figueras J, Sambuceti G, Schwaiger M, Mortelmans L,
Van de Werf F; PSALM investigators.
Am Heart J (2006) 152(1):1251-8.() |
Additional value of PET-CT in the
staging of lung cancer: comparison with CT alone, PET alone and visual
correlation of PET and CT.
De Wever W, Ceyssens S, Mortelmans L, Stroobants S, Marchal
G, Bogaert J, Verschakelen JA.
Eur Radiol (2006) 17(1):23-32.() |
The effect of a methyl or 2-fluoroethyl
substituent at the N-3 position of thymidine, 3'-fluoro-3'-deoxythymidine
and 1-beta-D-arabinosylthymine on their antiviral and cytostatic activity
in cell culture.
Balzarini J, Celen S, Karlsson A, de Groot T, Verbruggen A, Bormans
G.
Antivir Chem Chemother (2006) 17(1):17-23.() |
Repetitive (18)F-fluorodeoxyglucose
positron emission tomography in giant cell arteritis: A prospective
study of 35 patients.
Blockmans D, De Ceuninck L, Vanderschueren S, Knockaert D, Mortelmans
L, Bobbaers H.
Arthritis Rheum (2006) 55(1):131-137.() |
Biological evaluation of a technetium-99m-labeled
integrated tropane-BAT and its piperidine congener as potential
dopamine transporter imaging agents.
Kieffer DM, Vanbilloen HP, Cleynhens BJ, Terwinghe CY, Mortelmans
L, Bormans GM, Verbruggen AM.
Nucl Med Biol (2006) 33(1):125-33.() |
Magnetic resonance imaging after
radiofrequency ablation in a rodent model of liver tumor: tissue
characterization using a novel necrosis-avid contrast agent.
Ni Y, Chen F, Mulier S, Sun X, Yu J, Landuyt W, Marchal G, Verbruggen
A.
Eur Radiol (2006) 21(1):1-10.() |
Autologous bone marrow-derived
stem-cell transfer in patients with ST-segment elevation myocardial
infarction: double-blind, randomised controlled trial.
Janssens S, Dubois C, Bogaert J, Theunissen K, Deroose C, Desmet
W, Kalantzi M, Herbots L, Sinnaeve P, Dens J, Maertens J, Rademakers
F, Dymarkowski S, Gheysens O, Van Cleemput J, Bormans G, Nuyts J,
Belmans A, Mortelmans L, Boogaerts M, Van de Werf F.
Lancet (2006) 367(9505):113-21.() |
Structure-biodistribution relation
of neutral 99mTc(CO)3-complexes with tridentate N-substituted derivatives
of aminoethylglycine and phenylenediamine.
Rattat D, Cleynhens J, Terwinghe C, De Greve
A, Verbruggen A.
Tetrahedron Letters (2006) 47 4641-4645.() |
PET scan in lung cancer: current
recommendations and innovation.
Vansteenkiste JF, Stroobants SS.
J Thorac Oncol (2006) 1(1):71-3.() |
TOP
Small animal positron emission
tomography during vagus nerve stimulation in rats: a pilot study.
Dedeurwaerdere S, Cornelissen B, Van Laere K, Vonck K, Achten E,
Slegers G, Boon P.
Epilepsy Res (2005) 67(3):133-41.() |
Influence of experimentally induced
anxiety on gastric sensorimotor function in humans.
Geeraerts B, Vandenberghe J, Van Oudenhove L, Gregory LJ, Aziz Q,
Dupont P, Demyttenaere K, Janssens J, Tack J.
Gastroenterology (2005) 129(5):1437-44.() |
Prognostic relevance of response
evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission
tomography in patients with locally advanced non-small-cell lung
cancer.
Hoekstra CJ, Stroobants SG, Smit EF, Vansteenkiste J, van Tinteren
H, Postmus PE, Golding RP, Biesma B, Schramel FJ, van Zandwijk N,
Lammertsma AA, Hoekstra OS.
J Clin Oncol (2005) 23(33):8362-70.() |
Microglial imaging with positron
emission tomography and atrophy measurements with magnetic resonance
imaging in multiple sclerosis: a correlative study.
Versijpt J, Debruyne J, Van Laere K, Devos F, Keppens J, Strijckmans
K, Achten E, Slegers G, Dierckx R, Korf J, De Reuck J.
Mult Scler (2005) 11:127-134.() |
Characterisation and biodistribution
of two neutral (99m)Tc(CO)(3) complexes with a tridentate ligand.
Rattat D, Cleynhens B, Bormans G, Terwinghe C, Verbruggen A.
Bioorg Med Chem Lett (2005) 15(19):4192-5.() |
Positron emission tomography is
not a reliable method for the early diagnosis of cholangiocarcinoma
in patients with primary sclerosing cholangitis.
Fevery J, Buchel O, Nevens F, Verslype C, Stroobants S, Van Steenbergen
W.
J Hepatol (2005) 43(2):358-60.() |
Necrosis avid contrast agents:
functional similarity versus structural diversity.
Ni Y, Bormans G, Chen F, Verbruggen A, Marchal G.
Invest Radiol (2005) 40(8):526-35.() |
FDG-PET for preoperative staging
of bladder cancer.
Drieskens O, Oyen R, Van Poppel H, Vankan Y, Flamen P, Mortelmans
L.
Eur J Nucl Med Mol Imaging (2005) 32(12):1412-7.() |
Development and biological evaluation
of (99m)Tc-BAT-tropane esters.
Vanbilloen HP, Kieffer D, Cleynhens BJ, Bormans G, Mortelmans L,
Verbruggen AM.
Nucl Med Biol (2005) 32(6):607-12.() |
Status Gelasticus after temporal
lobectomy: ictal FDG-PET findings and the question of dual pathology
involving hypothalamic hamartomas.
Palmini A, Van Paesschen W, Dupont P, Van Laere K, Van Driel G.
Epilepsia (2005) 46(8):1313-6.() |
Feature-based statistical analysis
of structural MR data for automatic detection of focal cortical
dysplastic lesions.
Srivastava S, Maes F, Vandermeulen D, Van Paesschen W, Dupont P,
Suetens P.
Neuroimage (2005) 27(2):253-66.() |
Increased cerebral serotonin-2A
receptor binding in depressed patients with myocardial infarction.
Schins A, Van Kroonenburgh M, Van Laere K, D'haenen H, Lousberg
R, Crijns H, Eersels J, Honig A.
Psychiatry Res (2005) 139(2):155-63.() |
Comparison between MAP and postprocessed
ML for image reconstruction in emission tomography when anatomical
knowledge is available.
Nuyts J, Baete K, Beque D, Dupont P.
IEEE Trans Med Imaging (2005) 24(5):667-75.() |
Mucociliary transport using 99mTc-albumin
colloid: a reliable screening test for primary ciliary dyskinesia.
De Boeck K, Proesmans M, Mortelmans L, Van Billoen B, Willems T,
Jorissen M.
Thorax (2005) 60(5):414-7.() |
Consensus meeting for the management
of gastrointestinal stromal tumors * Report of the GIST Consensus
Conference of 20-21 March 2004, under the auspices of ESMO.
Blay JY, Bonvalot S, Casali P, Choi H, Debiec-Richter M, Dei Tos
AP, Emile JF, Gronchi A, Hogendoorn PC, Joensuu H, Le Cesne A, Mac
Clure J, Maurel J, Nupponen N, Ray-Coquard I, Reichardt P, Sciot
R, Stroobants S, van Glabbeke M, van Oosterom A, Demetri GD.
Ann Oncol (2005) 16(4):566-78.() |
Cost-effectiveness of F-fluorodeoxyglucose
positron emission tomography in the assessment of early dementia
from a Belgian and European perspective.
Moulin-Romsee G, Maes A, Silverman D, Mortelmans L, Van Laere K.
Eur J Neurol (2005) 12(4):254-63.() |
Synthesis, Characterization, and
Pharmacokinetic Evaluation of a Potential MRI Contrast Agent Containing
Two Paramagnetic Centers with Albumin Binding Affinity.
Parac-Vogt TN, Kimpe K, Laurent S, Vander Elst L, Burtea C, Chen
F, Muller RN, Ni Y, Verbruggen A, Binnemans K.
Chemistry (2005) 11(10):3077-3086.() |
Regional brain activation during
proximal stomach distention in humans: A positron emission tomography
study.
Vandenbergh J, Dupont P, Fischler B, Bormans G, Persoons P, Janssens
J, Tack J.
Gastroenterology (2005) 128(3):564-73.() |
Technetium-99m labelled integrated
tropane-BAT as a potential dopamine transporter tracer.
Cleynhens B.J, de Groot T.J, Vanbilloen H.P, Kieffer D, Mortelmans
L, Bormans G.M and Verbruggen A.M.
Bioorganic & Medicinal Chemistry (2005) 13(4):1053-1058.() |
The chemistry of the fac-[Re(CO)2(NO)]2+
Fragment in aqueous solution.
Kurz P, Rattat D, Angst D, Schmalle H, Spingler B, Alberto R, Berke
H and Beck W.
Dalton Transactions (2005) 21(4):804-810.() |
Optimization of geometrical calibration
in pinhole SPECT.
Beque D, Nuyts J, Suetens P, Bormans G.
IEEE Trans Med Imaging (2005) 24(2):180-90.() |
Direct comparison of (18)F-FDG and
(11)C-methionine PET in suspected recurrence of glioma: sensitivity,
inter-observer variability and prognostic value.
Van Laere K, Ceyssens S, Van Calenbergh F, De Groot T, Menten J, Flamen
P, Bormans G, Mortelmans L.
Eur J Nucl Med Mol Imaging (2005) 32(1):39-51.() |
TOP
Hodgkin's Lymphoma: Evolving Concepts
with Implications for Practice.
Meyer RM, Ambinder RF and Stroobants S.
Hematology Am Soc Hematol Educ Program ( 2004) 184-202.() |
Evaluation of hypoxia in an experimental
rat tumour model by [(18)F]Fluoromisonidazole PET and immunohistochemistry.
Dubois L, Landuyt W, Haustermans K, Dupont P, Bormans G, Vermaelen
P, Flamen P, Verbeken E, Mortelmans L.
Br J Cancer (2004) 91(11):1-8.() |
Evaluation of Early Treatment Response
and Predicting the Need for Colectomy in Active Ulcerative Colitis
with 99mTc-HMPAO White Blood Cell Scintigraphy.
Bennink RJ, Peeters M, Rutgeerts P, Mortelmans L.
J Nucl Med (2004) 45(10):1698-704.() |
Evaluation of anatomy based reconstruction
for partial volume correction in brain FDG-PET.
Baete K, Nuyts J, Van Laere K, Van Paesschen W, Ceyssens S, De Ceuninck
L, Gheysens O, Kelles A, Van Den Eynden J, Suetens P, Dupont P.
Neuroimage (2004) 23(1):305-17.() |
Dopamine Transporter SPECT using fast
kinetic ligands: (123)I-FP-beta-CIT versus (99m)Tc-TRODAT-1
Van Laere K, De Ceuninck L, Dom R, Van Den Eynden J, Vanbilloen H,
Cleynhens J, Dupont P, Maes A, Bormans G, Verbruggen A, Mortelmans
L
Eur J Nucl Med Mol Imaging (2004) 31(8):1119-27.() |
In vitro evaluation and biodistribution
of a 99mTc-labeled anti-VEGF peptide targeting neuropilin-1.
Perret GY, Starzec A, Hauet N, Vergote J, Le Pecheur M, Vassy R, Leger
G, Verbeke KA, Bormans G, Nicolas P, Verbruggen AM, Moretti JL.
Nucl Med Biol (2004) 31(5):575-81.() |
[M(CO)2(NO)]2+, a new core in bioorganometallic
chemistry: model complexes of [Re(CO)2(NO)]2+ and [99mTc(CO)2(NO)]2+
Rattat D, Verbruggen A, Schmalle H, Berke H, Alberto R
Tetrahedron Letters (2004) 45(21): 4089-4092.() |
Relation between different methods
for analysing ST segment deviation and infarct size as assessed by
positron emission tomography.
Desmet WJ, Mesotten LV, Maes AF, Heidbuchel HP, Mortelmans LA, Van
de Werf FJ.
Heart (2004) 90(8):887-92.() |
Contribution of (18)fluoro-deoxyglucose
positron emission tomography to the work-up of patients with fever
of unknown origin.
Buysschaert I, Vanderschueren S, Blockmans D, Mortelmans L, Knockaert
D.
Eur J Intern Med (2004) 15(3):151-156.() |
Position of positron emission tomography
and other imaging diagnostic modalities in esophageal cancer.
Flamen P, Lerut T, Haustermans K, Van Cutsem E, Mortelmans L.
Q J Nucl Med (2004) 48(2):96-108.() |
Color discrimination involves ventral
and dorsal stream visual areas.
Claeys K, Dupont P, Cornette L, Sunaert S, Van Hecke P, De Schutter
E and Orban GA.
Cerebral Cortex 14 (2004) 803-822.() |
Statistical Parametric Mapping of
(99m)Tc-ECD SPECT in Idiopathic Parkinson's Disease and Multiple System
Atrophy with Predominant Parkinsonian Features: Correlation with Clinical
Parameters.
Van Laere K, Santens P, Bosman T, De Reuck J, Mortelmans L, Dierckx
R.
J Nucl Med (2004) 45(6):933-42.() |
Exploring the nitrosyl-approach: “Re(CO)2(NO)”-
and “Tc(CO)2(NO)”- complexes provide new pathways for
bioorganometallic chemistry.
Rattat D, Verbruggen A, Berke H, Alberto R.
Journal of Organometallic Chemistry (2004) 689(25):4833-4836.() |
Quantifying myocardial deformation
throughout the cardiac cycle : a comparison of ultrasound strain rate,
grey-scale M-mode and magnetic resonance imaging.
Herbots L, Maes F, D'Hooge J, Claus P, Dymarkowski S, Mertens P, Mortelmans
L, Bijnens B, Bogaert J, Rademakers F, Sutherland G.
Ultrasound in Med & Biol (2004) 30(5):591-598.() |
18-fluoro-deoxyglucose positron emission
tomography may contribute to the diagnosis and follow-up of malakoplakia.
Vanbrabant P, Drieskens O, Blockmans D.
Acta Clin Belg (2004) 59(3):138-42.() |
Comment on Meller et al.: Value of
F-18 FDG hybrid camera PET and MRI in early Takayasu aortitis.
Vanderschueren S, Buysschaert I, Mortelmans L, Blockmans D, Knockaert
DC.
Eur Radiol (2004) 14(5):926-7.() |
The development of hippocampal sclerosis
in a patient with occipital lobe epilepsy and migraine.
Simons PJ, Van Paesschen W, Palmini A, Dupont P, Van Driel G, Van
Laere K.
Neurology (2004) 62(6):1024-1025.() |
99mTc-Ciprofloxacin imaging for the
diagnosis of infection in the postoperative spine.
Gemmel F, De Winter F, Van Laere K, Vogelaers D, Uyttendaele D, Dierckx
R.
Nucl Med Comm (2004) 25(3):277-283.() |
Anatomical-Based FDG-PET Reconstruction
for the Detection of Hypo-Metabolic Regions in Epilepsy.
Baete K, Nuyts J, Van Paesschen W, Suetens P, and Dupont P.
IEEE Trans Med Imag (2004) 23(4):510-519.() |
Comparison of tridentate ligands in
competition experiments for their ability to form a [99mTc(CO)3] complex.
Rattat D, Eraets K, Cleynhens B, Knight H, Fonge H and Verbruggen
A.
Tetrahedron Letters (2004) 45(12):2531-2534.() |
Embryonic endothelial progenitor cells
armed with a suicide gene target hypoxic lung metastases after intravenous
delivery.
Wei J.W, Blum S, Unger M, Jarmy G, Lamparter M, Geishauser A, Vlastos
G.A, Chan G, Fischer K.D, Rattat D, Debatin K.M, Hatzopoulos A.K,
Beltinger C.
Cancer Cell (2004) (5):477-488.() |
Positron emission tomography in the
management of non-small cell lung cancer.
Vansteenkiste JF, Stroobants SG.
Hematol Oncol Clin North Am (2004) 18(1):269-88.() |
99mTc-Ciprofloxacin planar and tomographic
imaging for the diagnosis of infection in the postoperative spine:
experience in 48 patients.
De Winter F, Gemmel F, Van Laere K, De Winter O, Poffijn B, Dierckx
R, Van De Wiele C.
Eur J Nucl Med Mol Imaging (2004) 31(2):233-239.() |
Oesophageal clearance of acid and
bile: a combined radionuclide, pH, and Bilitec study.
Koek GH, Vos R, Flamen P, Sifrim D, Lammert F, Vanbilloen B, Janssens
J, Tack J.
Gut (2004) 53(1):21-6.() |
TOP
Accumulation and photocytotoxicity
of hypericin and analogs in two- and three-dimensional cultures of
transitional cell carcinoma cells.
Huygens A, Huyghe D, Bormans G, Verbruggen A, Kamuhabwa AR, Roskams
T, de Witte PA.
Photochem Photobiol (2003) 78(6):607-14.() |
Neurostimulation for refractory epilepsy.
Vonck K, Boon P, Goossens L, Dedeurwaerdere S, Claeys P, Gossiaux
F, Van Hese P, De Smedt T, Raedt R, Achten E, Deblaere K, Thieleman
A, Vandemaele P, Thiery E, Vingerhoets G, Miatton M, Caemaert J, Van
Roost D, Baert E, Michielsen G, Dewaele F, Van Laere K, Thadani V,
Robertson D, Williamson P.
Acta Neurol Belg (2003) 103(4):213-217.() |
Synthesis of 18F-Fluoroalkyl-ß-D-Glucosides
and Their Evaluation as Tracers for Sodium-Dependent Glucose Transporters
.
de Groot TJ, Veyhl M, Terwinghe C, Vanden Bemp V, Dupont P, Mortelmans
L, Verbruggen AM, Bormans GM, Koepsell H.
J Nucl Med (2003) 44(12):1973-1981.() |
PET in Gastro-oesophageal Cancer.
Flamen P, Mortelmans L.
Chapter in : PET and PET-CT in Oncology Eds. Oehr P, Biersack
HJ, Coleman RE.
Springer 2003 Nov () |
Involvement of multiple functionally
distinct cerebellar regions in visual discrimination: a human functional
imaging study.
Claeys KG, Orban GA, Dupont P, Sunaert S, Hecke PV, Schutter ED.
Neuroimage (2003) 20(2):840-54.() |
18FDG-Positron emission tomography
for the early prediction of response in advanced soft tissue sarcoma
treated with imatinib mesylate (Glivec(R)).
Stroobants S, Goeminne J, Seegers M, Dimitrijevic S, Dupont P, Nuyts
J, Martens M, van den Borne B, Cole P, Sciot R, Dumez H, Silberman
S, Mortelmans L, van Oosterom A.
Eur J Cancer (2003) 39(14):2012-2020.() |
A penalized-likelihood image reconstruction
method for emission tomography, compared to postsmoothed maximum-likelihood
with matched spatial resolution.
Nuyts J, Fessler JA.
IEEE Trans Med Imaging (2003) 22(9):1042-1052.() |
An efficient HPLC method for the analysis
of isomeric purity of technetium-99m-exametazime and identity confirmation
using LC-MS.
Vanderghinste D, Van Eeckhoudt M, Terwinghe C, Mortelmans L, Bormans
GM, Verbruggen AM, Vanbilloen HP.
J Pharm Biomed Anal (2003) 32(4-5):679-685.() |
Imaging of large vessel vasculitis
with (18)FDG PET: illusion or reality? A critical review of the
literature data.
Belhocine T, Blockmans D, Hustinx R, Vandevivere J, Mortelmans L.
Eur J Nucl Med Mol Imaging (2003) 30(9):1305-13.() |
Synthesis and biologic evaluation
of 11C-methyl-D-glucoside, a tracer of the sodium-dependent glucose
transporters.
Bormans GM, Van Oosterwyck G, De Groot TJ, Veyhl M, Mortelmans L,
Verbruggen AM, Koepsell H.
J Nucl Med (2003) 44(7):1075-1081.() |
Cerebral regions processing first-
and higher-order motion in an opposed-direction discrimination task.
Dupont P, Sary G, Peuskens H, Orban GA.
Eur J Neurosci (2003) 17(7):1509-1517.()
|
Prognostic value of pretransplant
positron emission tomography using fluorine18-fluorodeoxyglucose in
patients with aggressive lymphoma treated with high-dose chemotherapy
and stem cell transplantation.
Spaepen K, Stroobants S, Dupont P, Vandenberghe P, Maertens J, Bormans
G, Thomas J, Balzarini J, De Wolf-Peeters C, Mortelmans L, Verhoef
G.
Blood. (2003) 102(1):53-59.() |
Assessment of neuroinflammation
and microglial activation in Alzheimer's disease with radiolabelled
PK11195 and single photon emission computed tomography. A pilot
study.
Versijpt JJ, Dumont F, Van Laere KJ, Decoo D, Santens P,
Audenaert K, Achten E, Slegers G, Dierckx RA, Korf J.
Eur Neurol (2003) 50(1):39-47.()
|
De novo cryptogenic refractory multifocal
febrile status epilepticus in the young adult: a review of six cases.
Van Lierde I, Van Paesschen W, Dupont P, Maes A, Sciot R.
Acta Neurol Belg (2003) 103(2):88-94.() |
Defining the transmurality of a chronic
myocardial infarction by ultrasonic strain-rate imaging: implications
for identifying intramural viability: an experimental study.
Weidemann F, Dommke C, Bijnens B, Claus P, D'hooge J, Mertens P, Verbeken
E, Maes A, Van De Werf F, De Scheerder I, Sutherland GR.
Circulation (2003) 107(6):883-888.() |
Positron emission tomography with
[(18)F]FDG for therapy response monitoring in lymphoma patients.
Spaepen K, Stroobants S, Verhoef G, Mortelmans L.
Eur J Nucl Med Mol Imaging (2003) 30(07)S97-S105.() |
SPECT perfusion changes during complex
partial seizures in patients with hippocampal sclerosis.
Van Paesschen W, Dupont P, Van Driel G, Van Billoen H, Maes A.
Brain (2003) 126(5):1103-1111.() |
Long-term electrical capsular stimulation
in patients with obsessive-compulsive disorder.
Nuttin BJ, Gabriels LA, Cosyns PR, Meyerson BA, Andreewitch S, Sunaert
SG, Maes AF, Dupont PJ, Gybels JM, Gielen F, Demeulemeester HG.
Neurosurgery (2003) 52(6):1263-1272.() |
Characterization of pinhole SPECT
acquisition geometry.
Beque D, Nuyts J, Bormans G, Suetens P, Dupont P.
IEEE Trans Med Imaging (2003) 22(5):599-612.() |
99mTc-TRODAT-M is not superior
to 99mTc-TRODAT-1 for the diagnosis of Parkinson's disease.
Maes A, Vanbilloen H, Cleynhens B, Mortelmans L, Bormans G, Verbruggen
A.
Eur J Nucl Med Mol Imaging (2003) 30(5):796-797.() |
Identity confirmation of 99mTc-MAG3,
99mTc-Sestamibi and 99mTc-ECD using radio-LC-MS.
Verduyckt T, Kieffer D, Huyghe D, Cleynhens B, Verbeke K, Verbruggen
A, Bormans G.
J Pharm Biomed Anal (2003) 32(4-5):669-678.() |
RP-HPLC separation of the diastereomers
of technetium-99m labelled tropanes and identity confirmation using
radio-LC-MS.
Vanbilloen HP, Cleynhens BJ, de Groot TJ, Maes A, Bormans GM, Verbruggen
AM.
J Pharm Biomed Anal (2003) 32(4-5):663-668.() |
The value of (18)FDG-PET for the
detection of infected hip prosthesis.
Vanquickenborne B, Maes A, Nuyts J, Van Acker F, Stuyck J, Mulier
M, Verbruggen A, Mortelmans L.
Eur J Nucl Med Mol Imaging (2003) 30(5):705-715.() |
Positron emission tomography with
FDG in the detection of peritoneal and retroperitoneal metastases
of ovarian cancer.
Drieskens O, Stroobants S, Gysen M, Vandenbosch G, Mortelmans L,
Vergote I.
Gynecol Obstet Invest (2003) 55(3):130-134.() |
Image-Derived Input Function for [11C]Flumazenil
Kinetic Analysis in Human Brain.
Sanabria-Bohorquez SM, Maes A, Dupont P, Bormans G, Groot T, Coimbra
A, Eng W, Laethem T, Lepeleire ID, Gambale J, Vega JM, Burns HD.
Mol Imaging Biol (2003) 5(2):72-8.() |
The potential value of ultrasonic
deformation measurement in differentiating regional ischaemic substrates
during dobutamine stress echocardiography.
Kowalski M, Herbots L, Weidemann F, Dommke C, Mertens P, Mortelmans
L, Bijnens B, Herregods MC, Sutherland GR.
Eur J Echocardiogr (2003) 4(1):23-28.() |
[(18)F]FDG PET monitoring of tumour
response to chemotherapy: does [(18)F]FDG uptake correlate with
the viable tumour cell fraction?
Spaepen K, Stroobants S, Dupont P, Bormans G, Balzarini
J, Verhoef G, Mortelmans L, Vandenberghe P, De Wolf-Peeters C.
Eur J Nucl Med Mol Imaging (2003) 30(5):682-8.() |
S-Trityl protection of bis-amino
bis-thiol (BAT) chelator enables flexible derivatisation and facile
labelling with technetium-99m.
Cleynhens B, Bormans G, Vanbilloen H, Vanderghinste D, Kieffer D,
de Groot T, Verbruggen A.
Tetrahedron Letters (2003) 44(12):2597-2600.() |
Evolution of regional performance
after an acute anterior myocardial infarction in humans using magnetic
resonance tagging.
Rademakers F, Van De Werf F, Mortelmans L, Marchal G, Bogaert J.
J Physiol (2003) 546( 3):777-787.()
|
Evaluation of 18F-FA-4 and 11C-pipzA-4
as radioligands for the in vivo evaluation of the high-affinity choline
uptake system.
Gilissen C, de Groot TJ, Bronfman F, van Leuven F, Verbruggen AM,
Bormans GM.
J Nucl Med (2003) 44(2):269-275.() |
Assessment of myocardial viability
in a porcine model of chronic coronary artery stenosis with dual dose
dobutamine magnetic resonance imaging.
Dymarkowski S, Szilard M, Maes A, Liu XS, Huang YM, Verbeken E, Mortelmans
L, Bogaert J, De Scheerder I.
Int J Cardiovasc Imaging (2003) 19(1):63-72.() |
Additional value of whole-body fluorodeoxyglucose
positron emission tomography in the detection of distant metastases
of non-small-cell lung cancer.
Stroobants SG, D'Hoore I, Dooms C, De Leyn PR, Dupont PJ, Wever WD,
Groot TD, Verschakelen JA, Mortelmans LA, Vansteenkiste JF.
Clin Lung Cancer (2003) 4(4):242-7.()
|
TOP
Cardiac phantom measurement validating
the methodology for a cardiac multi-centre trial with positron emission
tomography.
Nuyts J, Mortelmans L, Van De Werf F, Djian J, Sambuceti G, Schwaiger
M, Touboul P, Maes A.
Eur J Nucl Med Mol Imaging (2002) 29(12):1588-1593.() |
Use of excess height and cluster
extent in subtraction SPECT.
Baete K, Nuyts J, Van Paesschen W, Maes A, Ghoorun S, Suetens P,
Dupont P.
IEEE Trans Nucl Sci (2002) 5 (10):2332-2337.()
|
Early restaging positron emission
tomography with (18)F-fluorodeoxyglucose predicts outcome in patients
with aggressive non-Hodgkin's lymphoma.
Spaepen K, Stroobants S, Dupont P, Vandenberghe P, Thomas J, De
Groot T, Balzarini J, De Wolf-Peeters C, Mortelmans L, Verhoef G.
Ann Oncol (2002) 13(9):1356-1363.() |
Necrosis-avid contrast agents: introducing
nonporphyrin species.
Ni Y, Cresens E, Adriaens P, Miao Y, Verbeke K, Dymarkowski S, Verbruggen
A, Marchall G.
Acad Radiol (2002) 9(1):S98-101.() |
Reducing Loss of Image Quality
Because of the Attenuation Artifact in Uncorrected PET Whole-Body
Images.
Nuyts J, Stroobants S, Dupont P, Vleugels S, Flamen P, Mortelmans
L.
J Nucl Med (2002) 43(8):1054-1062.() |
Measurement of perfusion in stage
IIIA-N2 non-small cell lung cancer using H(2)(15)O and positron
emission tomography.
Hoekstra C, Stroobants S, Hoekstra O, Smit E, Vansteenkiste J, Lammertsma
A.
Clin Cancer Res (2002) 8(7):2109-2115.() |
18FDG PET scan in the staging of
recurrent melanoma : additional value and therapeutic impact.
Stas M, Stroobants S, Dupont P, Gysen M, Van Hoe L, Garmyn L, Mortelmans
L, De Wever I.
Melanoma Research (2002) 12:479-490.() |
Role of FDG-PET scan in staging of
cancer of the esophagus and gastroesophageal junction.
Lerut T, Flamen P.
Minerva Chir (2002) 57(6):837-845.() |
Riedel's thyroiditis and retroperitoneal
fibrosis in multifocal fibrosclerosis: positron emission tomographic
findings.
Drieskens O, Blockmans D, Van den Bruel A, Mortelmans L.
Clin Nucl Med (2002) 27(6):413-415.() |
On estimating the variance of smoothed
MLEM images.
Nuyts J.
IEEE Trans Nucl Sci (2002) 49 (6):714-721.() |
Dissociation of cardiomyocyte apoptosis
and dedifferentiation in infarct border zones.
Dispersyn G, Mesotten L, Meuris B, Maes A, Mortelmans L, Flameng
W, Ramaekers F, Borgers M.
Eur Heart J (2002) 23(11):849-857.() |
Update of phase I study of imatinib
(STI571) in advanced soft tissue sarcomas and gastrointestinal stromal
tumors: a report of the EORTC Soft Tissue and Bone Sarcoma Group.
van Oosterom AT, Judson IR, Verweij J, Stroobants S, Dumez H, Donato
dP, Sciot R, Van Glabbeke M, Dimitrijevic S, Nielsen OS.
Eur J Cancer (2002) 38 (5):S83-S87.() |
Preparation and preliminary evaluation
of 99mTc-EC-For-MLFK.
Verbeke K, Verbeke A, Vanbilloen H, Verbruggen A.
Nucl Med Biol (2002) 29(5):585-592.() |
Whole-body PET with FDG for the
diagnosis of recurrent gastric cancer.
De Potter T, Flamen P, Van Cutsem E, Penninckx F, Filez L, Bormans
G, Maes A, Mortelmans L.
Eur J Nucl Med (2002) 29(4):525-529.() |
Clinical relevance of thyroid fluorodeoxyglucose-whole
body positron emission tomography incidentaloma.
Van den Bruel A, Maes A, De Potter T, Mortelmans L, Drijkoningen
M, Van Damme B, Delaere P, Bouillon R.
J Clin Endocrinol Metab (2002) 87(4):1517-1520.() |
Positron emission tomography can
reveal abdominal periaortitis.
Blockmans D, Van Moer E, Dehem J, Feys C, Mortelmans L.
Clin Nucl Med (2002) 27(3):211-212.() |
Positron emission tomography for
assessment of the response to induction radiochemotherapy in locally
advanced oesophageal cancer.
Flamen P, Van Cutsem E, Lerut A, Cambier JP, Haustermans K, Bormans
G, De Leyn P, Van Raemdonck D, De Wever W, Ectors N, Maes A, Mortelmans
L.
Ann Oncol (2002) 13(3):361-368.() |
Preservation of parotid function with
uncomplicated conformal radiotherapy.
Maes A, Weltens C, Flamen P, Lambin P, Bogaerts R, Liu X, Baetens
J, Hermans R, van den Bogaert W.
Radiother Oncol (2002) 63(2):203-211.() |
Factor analysis in prostate cancer:
delineation of organ structures and automatic generation of in-
and output functions.
Schiepers C, Hoh K, Nuyts J, Wu H-M, Phelps ME, Dahlbom M.
IEEE Trans Nucl Sci (2002) 49(5):2338-2343.() |
Human brain regions involved in visual
categorization.
Vogels R, Sary G, Dupont P, Orban GA.
Neuroimage (2002) 16(2):401-414.() |
Positron emission tomography in colorectal
cancer.
Flamen P.
Best Pract Res Clin Gastroenterol (2002) 16(2):237-251.() |
A concave prior penalizing relative
differences for maximum-a-posteriori reconstruction in emission
tomography.
Nuyts J, Bequé D, Dupont P, Mortelmans L.
IEEE Trans Nucl Sci (2002) 49(1):56-60.() |
FDG-PET scan in the diagnosis of
postmeningococcal pericarditis.
Blockmans D, Stroobants S, Vanderschueren S, Peetermans W, Bobbaers
H, Mortelmans L.
Clin Nuc Med (2002) 27(1):59.() |
PET radiopharmaceuticals used in
viability studies in acute myocardial infarction: a literature survey.
Mesotten L, Maes A, Van de Werf F, Mortelmans L.
Eur J Nucl Med (2002) 29(1):3-6.() |
Passage of inhaled Particles into
the blood circulation in humans.
Nemmar A, Hoet P, Vanquickenborne B, Dinsdale D, Thomeer M, Hoylaerts
M, Vanbilloen H, Mortelmans L, Nemery B.
Circulation (2002) 105(4):411-414.() |
Pertechnegas lung clearance in
different forms of interstitial lung disease.
Thomeer M, Dehaes B, Mortelmans L, Demedts M.
Eur Respir J (2002) 19(1):31-36.() |
The neural substrate of orientation
short-term memory and resistance to distractor items.
Cornette L, Dupont P, Orban GA.
Eur J Neurosci (2002) 15(1):165-175.() |
Exploring multifunctional features
of necrosis avid contrast agents.
Ni Y, Cresens E, Adriaens P, Dymarkowski S, Bogaert J, Zhang H, Bosmans
H, Verbruggen A, Marchal G.
Acad Radiol (2002) 9 (2):S488-S490.() |
Development of a conjugate of (99m)Tc-EC
with aminomethylenediphosphonate in the search for a bone tracer with
fast clearance from soft tissue.
Verbeke K, Rozenski J, Cleynhens B, Vanbilloen H, De Groot T, Weyns
N, Bormans G, Verbruggen A.
Bioconjug Chem (2002) 13(1):16-22.() |
TOP
Excess height vs. cluster extent
in subtraction SPECT.
Baete K, Nuyts J, Maes A, Van Paesschen W, Dupont P.
Tijdschrift voor Nucleaire Geneeskunde (2001) 23(4):165.() |
Separate Neural Correlates for
the Mnemonic Components of Successive Discrimination and Working
Memory Tasks.
Cornette L, Dupont P, Bormans G, Mortelmans L, Orban G.
Cereb Cortex (2001) 11: 59-72.() |
Clinical value of [18F] fluoro-deoxyglucose
positron emission tomography for patients with fever of unknown
origin.
Blockmans D, Knockaert D, Maes A, De Caestecker J, Stroobants S,
Bobbaers H, Mortelmans L.
Clin Infect Dis (2001) 32:191-196.() |
Tc-99m HMPAO white blood cell scintigraphy
in the assessment of the extent and severity of an acute exacerbation
of ulcerative colitis.
Bennink R, Peeters M, D’Haens G, Rutgeerts P, Mortelmans L.
Clin Nucl Med (2001) 26(2):99-104.() |
Prognostic value of positron emission
tomography (PET) with fluorine-18 fluorodeoxyglucose.
Spaepen S, Stroobants S, Dupont P, Van Steenweghen S, Thomas J,
Vandenberghe P, Vanuytsel L, Bormans G, Balzarini J , De Wolf-Peeters
C, Mortelmans L, Verhoef G
J Clin Oncol (2001) 19(2):414-419.() |
Early assessment of regional myocardial
blood flow and metabolism in thrombolysis in myocardial infarction
flow grade 3 reperfused myocardial infarction using carbon-11-acetate.
Maes A, Van de Werf F, Mesotten L, Flamen P, Kuzo R, Nuyts J, Mortelmans
L
J Am Coll Cardiol (2001) 37(1):30-36.() |
The utility of SPECT in determining
the relationship between radiation dose and salivary gland dysfunction
after radiotherapy
Van Acker F, Flamen P, Lambin P , Maes A, Kutcher G, Weltens C,
Hermans R, Baetens J, Dupont P, Rijnders A, Maes A, Van den Bogaert
W, Mortelmans L
Nucl Med Comm (2001) 22:225-231.() |
Unexplained rising carcinoembryonic
antigen (CEA) in the postoperative surveillance of colorectal cancer:
the utility of positron emission tomography (PET)
Flamen P, Hoekstra O, Homans F, Van Cutsem E, Maes A, Stroobants
A, Peeters M, Penninckx F, Filez L, Bleichrodt R, Mortelmans L
Eur J Cancer (2001) 37:862-869.() |
PET “reversed mismatch pattern”
early after acute myocardial infarction: follow-up of flow, metabolism
and function
Mesotten L, Maes A, Herregods M, Desmet W, Nuyts J, Van de Werf
F, Mortelmans L.
Eur J Nucl Med (2001) 28(4):466-471.() |
Image-correction techniques in SPECT
Bouwens L, Van de Walle R, Nuyts J, Koole M, D'Asseler Y, Vandenberghe
S, Lemahieu I, Dierckx R.A.
Computerized Medical Imaging and Graphics (2001) 25:117-126.() |
PET reversed mismatch in an experimental
model of subacute myocardial infarction
Mesotten L, Dispersyn G, Maes A, Zietkiewicz M, Nuyts J, Bormans
G, de Groot T, Borgers M, Mortelmans L, Flameng W
Eur J Nucl Med (2001) 28(4):457-465.() |
Clinical value of whole-bodu positron
emission tomography in potentially curable colorectal liver metastases
Topal B, Flamen P, Aerts R, D’Hoore A, Filez L , Van Cutsem
E, Mortelmans L, Penninckx F
Eur J Surg Oncol (2001) 27:175-179.() |
Intravenous cyclosporine versus
intravenous corticosteroids as single therapy for severe attacks
of ulcerative colitis
D'Haens G, Lemmens L, Geboes K, Vandeputte L, Van Acker F, Mortelmans
L, Peeters M, Vermeire S, Penninckx F, Nevens F, Hiele M, Rutgeerts
P.
Gastroenterology (2001) 120(6):1323-1329.() |
Ga-67-positive and F-18 FDG-negative
imaging in well-differentiated hepatocellular carcinoma.
Braga F, Flamen P, Mortelmans L, Stroobants S, Homans F, Maes A.
Clin Nucl Med (2001) 26(8):706.() |
FDG-PET, 99mTc-HMPAO white blood
cell SPECT and bone scintigraphy in the evaluation of painful total
knee arthroplasties
Van Acker F, Nuyts J, Maes A, Vanquickenborne B, Stuyck J, Bellemans
J, Vleugels S, Bormans G, Mortelmans L.
Eur J Nucl Med (2001) 28(10):1496-1504.() |
Neural tuberculosis detected by
F-18 FDG positron emission tomography.
Braga F, Maes A, Vansteenkiste P, Flamen P, Peetermans W, Mortelmans
L.
Clin Nucl Med (2001) 26(8):706.() |
Bone scintigraphy in testicular
tumors.
Braga F, Arbex M, Haddad J, Maes A.
Clin Nucl Med (2001) 26(2):117-118.() |
Parathyroid imaging : basic principles
and KULeuven experience : MIBI-dual phase versus MIBI/I-123.
Ceyssens S, Mortelmans L
Acta Otorhinolaryngol Belg (2001) 55(2):103-117.() |
FDG positron emission tomographic
scintigraphy can reveal Castleman's disease as a cause of inflammation
Blockmans D, Maes A, Stroobants S, Bobbaers H, Mortelmans L
Clin Nucl Med (2001) 26(11):975-976.() |
Can positron emission tomography
with [(18)F]-fluorodeoxyglucose after first-line treatment distinguish
Hodgkin's disease patients who need additional therapy from others
in whom additional therapy would mean avoidable toxicity?
Spaepen K, Stroobants S, Dupont P, Thomas J, Vandenberghe P, Balzarini
J, De Wolf-Peeters C, Mortelmans L, Verhoef G
Br J Haematol (2001) 115(2):272-278.() |
Evaluation of treatment response
in patients with lymphoma using [18F]FDG-PET : differences between
non-Hodgkin’s lymphoma ans Hodgkin’s disease.
Spaepen K, Mortelmans L
Q J Nucl Med (2001) 45(3):269-273.() |
The neural substrate of orientation
working memory.
Cornette L, Dupont P, Salmon E, Orban GA.
J Cogn Neurosci (2001) 13(6):813-828.() |
An iterative maximum-likelihood polychromatic
algorithm for CT.
De Man B, Nuyts J, Dupont P, Marchal G, Suetens P.
IEEE Trans Med Imaging (2001) 20(10):999-1008.() |
In vitro affinity of 99Tcm-labelled
N2S2 conjugates of chrysamine G for amyloid deposits of systemic amyloidosis.
Dezutter NA, Sciot RM, de Groot TJ, Bormans GM, Verbruggen AM.
Nucl Med Commun (2001) 22(5):553-558.() |
Evaluation of 99mTc-MAMA-chrysamine
G as an in vivo probe for amyloidosis.
Dezutter NA, Landman WJ, Jager PL, de Groot TJ, Dupont PJ, Tooten
PC, Zekarias B, Gruys E, Verbruggen AM.
Amyloid (2001) 8(3):202-214.() |
Progressive bouts of acute abdomen:
pet the peritoneum.
Laleman W, Vanderschueren S, Mortelmans L, Knockaert DC.
Acta Clin Belg (2001) 56(1):46-50.() |
Passage of intratracheally instilled
ultrafine particles from the lung into the systemic circulation in
hamster.
Nemmar A, Vanbilloen H, Hoylaerts MF, Hoet PH, Verbruggen A, Nemery
B.
Am J Respir Crit Care Med (2001) 164(9):1665-1668.() |
Maximum-likelihood expectation-maximization
reconstruction of sinograms with arbitrary noise distribution using
NEC-transformations.
Nuyts J, Michel C, Dupont P.
IEEE Trans Med Imaging (2001) 20(5):365-375.() |
Human brain regions involved in heading
estimation.
Peuskens H, Sunaert S, Dupont P, Van Hecke P, Orban GA.
J Neurosci (2001) 21(7):2451-2461.() |
Safety and efficacy of imatinib (STI571)
in metastatic gastrointestinal stromal tumours: a phase I study.
van Oosterom AT, Judson I, Verweij J, Stroobants S, Donato dP, Dimitrijevic
S, Martens M, Webb A, Sciot R, Van Glabbeke M, Silberman S, Nielsen
OS.
Lancet (2001) 358(9291):1421-1423.() |
The role of positron emission tomography
with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology.
Vansteenkiste JF, Stroobants SG.
Eur Respir J (2001) 17(4):802-820.() |
|
TOP
Remote myocardial dysfunction after
acute anterior myocardial infarction: impact of left ventricular shape
on regional function: a magnetic resonance myocardial tagging study.
Bogaert J, Bosmans H, Maes A, Suetens P, Marchal G, Rademakers F.
J Am Coll Cardiol (2000) 35(6):1525-1534.() |
Positron emission tomography in giant
cell arteritis and polymyalgia rheumatica: evidence for inflammation
of the aortic arch.
Blockmans D, Stroobants S, Maes A, Mortelmans L.
Am J Medicine (2000) 108(2):246-249.() |
A nonsurgical porcine model of left
ventricular dysfunction. Validation of myocardial viability using
dobutamine stress echocardiography and positron emission tomography.
Szilard M, Mesotten L, Maes A, Liu X, Nuyts J, Bormans G, De Groot
T, Pislaru S, Huang Y, Qiang B, Dispersyn G, Borgers M, Flameng W,
Van De Werf F, Mortelmans L, De Scheerder I.
Int J Cardiovasc Intervent (2000) 3(2):111-120.() |
Coronary radiation therapy with liquid
rhenium-186: a first clinical experience.
Coussement P, Stella P, Vanbilloen H, Verbruggen A, van Rijk P, Van
Limbergen E, de Jaegere P, De S, I.
J Invasive Cardiol (2000) 12(4):206-210.() |
Positron emission tomography scans
in colorectal cancer.
Penninckx F, Mortelmans L.
Perspect Colon Rectal Surgery (2000) 12(12): 1-37.() |
Hunter syndrome.
De Surgeloose D, Appel B, Dom L, Seynaeve P, Mortelmans L.
JBR-BTR (2000) 83(1):13.()
|
Self injection ictal SPECT during
partial seizures.
Van Paesschen W, Dupont P, van Heerden B, Vanbilloen H, Mesotten L,Maes
A, Van Driel G, Mortelmans L.
Neurology (2000) 54:1994-1997.() |
Reduction of contamination risks during
clinical studies with Technegas (Letter).
Vanbilloen H, Mortelmans L, Verbruggen A.
Eur J Nucl Med (2000) 27:237-240.() |
Scintigraphic evaluation in rabbits
of nasal drug delivery systems based on carbopol 971p® and carboxymethylcellulose.
Ugwoke M, Agu R, Vanbilloen H, Baetens J, Augustijns P, Verbeke N,
Mortelmans L, Verbruggen A, Kinget R, Bormans G.
J Controlled Release (2000) 207-214.() |
A new imaging technique for colorectal
cancer: positron emission tomography.
Flamen P, Van Cutsem E, Mortelmans L.
Semin Oncol (2000) 27(5)22-29.() |
Histopathologic validation of lymph
node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal
junction.
Lerut T, Flamen P, Ectors N, Van Cutsem E, Peeters M, Hiele M, Van
Cutsem E, Hiele M, De Wever W, Coosemans W, Decker G, De Leyn P, Deneffe
G, Van Raemdonck D, Mortelmans L.
Ann Surgery (2000) 232(6):743-752.() |
A nonsurgical porcine model of left
ventricular dysfunction. Validation of myocardial viability using
dobutamine stress echocardiography and positron emission tomography.
Szilard M, Mesotten L, Maes A, Liu X, Nuyts J, Bormans G, de Groot
T, Pislaru S, Huang Y, Qiang B, Dispersyn G, Borgers M, Flameng W,
Van de Werf F, Mortelmans L, De Scheerder I.
Int J Cardiovasc Intervent (2000) 3:111-120.() |
The utility of positron emission tomography
for the diagnosis and staging of recurrent esophageal cancer.
Flamen P, Lerut A, Van Cutsem E, Cambier JP, Maes A, De Wever W, Peeters
M, De Leyn P, Van Raemdonck D, Mortlemans L.
J Thorac Cardiovasc Surg (2000) 120(6):1085-1092.() |
Utility of positron emission tomography
for the staging of patients with potentially operable esophageal carcinoma.
Flamen P, Lerut A, Van Cutsem E, De Wever W, Peeters M, Stroobants
S, Dupont P, Bormans G, Hiele M, De Leyn P, Van Raemdonck D, Coosemans
W, Ectors N, Haustermans K, Mortelmans L.
J Clin Oncol (2000) 18(18):3202-3210.() |
Positron emission tomography scan
in the diagnosis and follow-up of aortitits of the thoracic aorta.
Derdelinckx I, Maes A, Bogaert J, Mortelmans L, Blockmans D.
Acta Cardiol (2000) 55(3):193-195.() |
Patient preparation for FDG imaging.
Maes A, Mortelmans L.
New Advances in Nuclear Cardiology (2000) 1(4): 9-10.() |
Synthesis and evaluation of the (99m)tc-complexes
of L-cysteine acetyldiglycine (a hybrid of MAG3 and L,L-EC) and of
L-beta-homocysteine acetyldiglycine.
Mang'era K, Vanbilloen H, Cleynhens B, De Groot T, Bormans G, Verbruggen
A, Verbeke K.
Nucl Med Biol (2000) 27(8):781-789.() |
Synthesis and biological evaluation
of the four isomers of technetium-99m labeled ethylenecysteamine cysteine
((99m)Tc-ECC), the mono-acid derivative of (99m)tc-L,L-ethylenedicysteine.
Vanbilloen HP, Cleynhens BJ, Verbruggen AM.
Nucl Med Biol (2000) 27(2):207-214.() |
Maintaining and shifting attention
within left or right hemifield.
Vandenberghe R, Duncan J, Arnell KM, Bishop SJ, Herrod NJ, Owen AM,
Minhas PS, Dupont P, Pickard JD, Orban GA.
Cereb Cortex (2000) 10(7):706-713.() |
The impact of (18)F-fluoro-2-deoxy-D-glucose
positron emission tomography (FDG-PET) lymph node staging on the radiation
treatment volumes in patients with non-small cell lung cancer.
Vanuytsel LJ, Vansteenkiste JF, Stroobants SG, De Leyn PR, De Wever
W, Verbeken EK, Gatti GG, Huyskens DP, Kutcher GJ.
Radiother Oncol (2000) 55(3):317-324.() |
Influence of the bifunctional chelate
on the biological behavior of (99m)Tc-labeled chemotactic peptide
conjugates.
Verbeke K, Snauwaert K, Cleynhens B, Scheers W, Verbruggen A.
Nucl Med Biol (2000) 27(8):769-779.() |
TOP
Synthesis of l-[18F] fluorodeoxyglucose:
an unexpected rearrangement in the reaction of 2-O-methanesulfonyl-b-D-mannopyranose
with [18F] fluoride.
de Groot T, Bormans G, Busson R, Mortelmans L, Verbruggen A.
J Labelled Comp Radiopharm (1999) 42:147-157.() |
Additional value of whole-body positron
emission tomography with Fluorine-18-2-Fluoro-2-deoxyD-glucose in
recurrent colorectal cancer.
Flamen P, Stroobants S, Van Cutsem E, Dupont P, Bormans G, De Vadder
N, Penninckx F, Van Hoe L, Mortelmans L.
J Clin Oncol (1999) 17(3):894-901.() |
Nuclear Cardiology, Part IV: Viability.
Mesotten L, Maes A, Hambye AS, Everaert H, Van den Maegdenbergh
V, Franken P, Mortelmans L.
J Nucl Med Technol (1999) 27(2):93-102.()
|
New arguments for a vasculitic nature
of polymyalgia rheumatica using positron emission tomography.
Blockmans D, Maes A, Stroobants S, Nuyts J, Bormans G, Knockaert D,
Bobbaers H, Mortelmans L.
Rheumatology (1999) 38:444-447.() |
Simple design for rapid self-injection
ictal SPECT during aura.
Vanbilloen H, Dupont P, Mesotten L, Mortelmans L, Verbeke K, Verbruggen
A, Van Paesschen W, Van Driel G.
Eur J Nucl Med (1999) 26(10):1380-1381.() |
Regional brain activity during shape
recognition impaired by a scopolamine challenge to encoding.
Rosier A, Cornette L, Dupont P, Bormans G, Mortelmans L, Orban G.
Eur J Neurosci (1999) 11:3701-3714.() |
Serum tissue polypeptide antigen (TPA):
monoclonal or polyclonal radio-immunometric assay for the follow-up
of bladder cancer.
Bennink R, Van Poppel H, Billen J, Decoster M, Baert L, Mortelmans
L, Blanckaert N.
Anticancer Res (1999) 19:2609-2614.() |
FDG-PET in the locoregional lymph
node staging of non-small cell lung cancer: a comprehensive review
of the Leuven Lung Cancer Group Experience.
Vansteenkiste J, Mortelmans L.
Clin Positron Imaging (1999) 2(4):223-231.() |
Reduction of contamination risks during
clinical studies with Technegas.
Vanbilloen H, Bauwens J, Mortelmans L, Verbruggen A.
Eur J Nucl Med (1999) 26(10):1349-1352.() |
Brain activity underlying stereotyped
and non-stereotyped retrieval of learned stimulus-response associations.
Vandenberghe R, Dupont P, Bormans G, Mortelmans L, Orban G.
Eur J Neurosci (1999) 11:4037-4050.() |
Validation of the lactose-(13C)ureide
breath test for determination of orocecal transit time.
Geypens B, Benninck R, Peeters M, Evenepoel P, Mortelmans L, Maes
B, Ghoos Y, Rutgeerts P.
J Nucl Med (1999) 40(9):1451-1455.() |
Simultaneous maximum a posteriori
reconstruction of attenuation ans activity distributions from emission
sinograms.
Nuyts J, Dupont P, Stroobants S, Benninck R, Mortelmans L, Suetens
P
IEEE Trans Med Imag (1999) 18(5):393-403.()
|
Evaluation of small-bowel transit
for solid and liquid test meal in healthy men and women.
Bennink R, Peeters M, Van den Maegdenbergh V, Geypens B, Rutgeerts
P, De Roo M, Mortelmans L.
Eur J Nucl Med (1999) 26(12):1560-1566.() |
Functional recovery of subepicardial
myocardial tissue in transmural myocardial infarction after successful
reperfusion.
Bogaert J, Maes A, Van de Werf F, Bosmans H, Herregodts MC, Nuyts
J, Desmet W, Mortelmans L, Marchal G, Rademakers F.
Circulation (1999) 99:36-43.() |
Evaluation of maximum-likelihood based
attenuation correction in positron emission tomography.
Nuyts J, Dupont P, Stroobants S, Maes A, Mortelmans L, Suetens P.
IEEE Trans Nucl Sci (1999) 46(4):1136-1141.() |
Prognostic importance of the standardized
uptake value on 18F-Fluoro-2deoxy-glucose-positron emission tomography
scan in non-small-cell lung cancer: an analysis of 125 cases.
Vansteenkiste J, Stroobants S, Dupont P, De Leyn P, Verbeken E, Deneffe
G, Mortelmans L, Demedts M, Leuven Lung Cancer Group.
J Clin Oncol (1999) 17(10):3201-3206.() |
99mTc-MAMA-chrysamine G, a probe for
beta-amyloid protein of Alzheimer's disease.
Dezutter NA, Dom RJ, de Groot TJ, Bormans GM, Verbruggen AM.
Eur J Nucl Med (1999) 26(11):1392-1399.() |
HPLC separation of 99mTc-L-cysteine
acetyldiglycine diethylester and its monoester-monoacid and diacid
derivatives.
Mang'era KO, Verbruggen A.
J Pharm Biomed Anal (1999) 21(3):679-683.() |
TOP
Nuclear Cardiology: part 3, Scintigraphic
evaluation of cardiac perfusion.
Everaert H, Maes A, Hambye AS, Mesotten L, Mortelmans L, Franken P.
J Nucl Med Technol (1998) 26:164-169.() |
Nuclear Cardiology: part 2, Scintigraphic
evaluation of cardiac function.
Hambye A, Everaert H, Maes A, Mesotten L, Vandevivere J, Mortelmans
L, Franken P.
J Nucl Med Technol (1998) 26:72-79.() |
Nuclear Cardiology: Part 1, general
introduction: anatomy and function of the normal heart.
Mesotten L, Maes A, Hambye AS, Everaert H, Van den Maegdenbergh V,
Franken P, Mortelmans L.
J Nucl Med Technol (1998) 26:4-8.() |
Segmental comparison between coronary
angiography and PET reveals low predictive value of epicardial flow
for viability.
Koszegi Z, Maes A, Piessens J, Van de Werf F, Mortelmans L.
Eur Heart Journal. (1998) 19:959-967.() |
Extraskeletal uptake of Tc-99m at
subcutaneous injection sites in a diabetic patient.
Gysen M, Verlooy H, Mortelmans L.
Clin Nucl Med (1998) 23(2):118-119.() |
Iterative reconstruction for helical
CT : a simulation study.
Nuyts J, De Man B, Dupont P, Defrise M, Suetens P, Mortelmans L.
Phys Med Biol (1998) 43:729-737.() |
Regions in the human brain activated
by simultaneous orientation discrimination: a study with positron
emission tomography.
Dupont P, Vogels R, Vandenberghe R, Rosier A, Cornette L, Bormans
G, Mortelmans L, Orban G.
Eur J Neurosci (1998) 10:3689-3699.() |
Human brain activity related to speed
discrimination tasks.
Orban G, Dupont P, De Bruyn B, Vandenberghe R, Rosier A, Mortelmans
L.
Exp Brain Res (1998) 122 :9-22.() |
Human brain regions involved in direction
discrimination.
Cornette L, Dupont P, Rosier A, Sunaert A, Van Hecke P, Michiels J,
Mortelmans L, Orban GA.
J Neurophysiology (1998) 79:2749-2765.() |
Human cerebral activity evoked by
motion reversal and motion onset. A PET study.
Cornette L, Dupont P, Spileers W, Sunaert S, Michiels J, Van Hecke
P, Mortelmans L, Orban G.
Brain (1998) 121:143-157.() |
Lymph node staging in non-small cell
lung cancer with FDG-PET scan: a prospective study on 690 lymph node
stations from 68 patients.
Vansteenkiste J, Stroobants S, De Leyn P, Dupont P, Bogaert J, Maes
A, Deneffe G, Nackaerts K, Verschakelen J, Lerut T, Mortelmans L,
Demedts M.
J Clin Oncol (1998) 16:2142-2149.() |
Technetium-Sestamibi Imaging: A valuable
method of evaluating myocardial viability.
Maes A, Borgers M, Flameng W, Nuyts J, Mortelmans L.
Cardiology Review (1998) 15(1):29-32.() |
Pulmonary tumor microembolism: Tumorbedingte
Lungen-Mikroembolie.
Bennink R, Van Wijngaerden E, De Roo M, Mortelmans L.
Nuklearmedizin (1998) 37:153-155.() |
Proliferative myositis: a case of
a pseudomalignant process.
Gysen M, Stroobants S, Mortelmans L.
Clin Nucl Med (1998) 23(12):836-838.() |
Comparison of total and compartmental
gastric emptying and antral motility between healthy men and women.
Bennink R, Peeters M, Van den Maegdenbergh V, Geypens B, Rutgeerts
P, De Roo M, Mortelmans L.
Eur J Nucl Med (1998) 25(9):1293-1299.() |
FDG-PET scan in potentially operable
non-small cell lung cancer: do anatometabolic PET-CT fusion images
improve the localisation of regional lymph node metastases?
Vansteenkiste J, Stroobants S, Dupont P, De Leyn P, De Wever W, Verbeken
E, Nuyts J, Maes F, Bogaert J, the Leuven Lung Cancer Group.
Eur J Nucl Med (1998) 25(11):1495-1501.() |
Measurement of skeletal flow with
positron emission tomography and 18F-fluoride in femoral head osteonecrosis.
Schiepers C, Broos P, Bormans G, De Roo M.
Arch Orthop Trauma Surg (1998) 118: 131-135.() |
Laryngeal tumor volume measurements
determined with CT: a study on intra- and interobserver variability.
Hermans R, Feron M, Bellon E, Dupont P, van den BW, Baert AL.
Int J Radiat Oncol Biol Phys (1998) 40(3):553-557.() |
Effect of clopidogrel on naproxen-induced
gastrointestinal blood loss in healthy volunteers.
van Hecken A, Depre M, Wynants K, Vanbilloen H, Verbruggen A, Arnout
J, Vanhove P, Cariou R, De Schepper PJ.
Drug Metabol Drug Interact (1998) 14(3):193-205.() |
Importance of the two ester functions
for the brain retention of 99mTc-labelled ethylene dicysteine diethyl
ester (99mTc-ECD).
Vanbilloen HP, Cleynhens BJ, Verbruggen AM.
Nucl Med Biol (1998) 25(6):569-575.() |
FDG-PET scan in potentially operable
non-small cell lung cancer: do anatometabolic PET-CT fusion images
improve the localisation of regional lymph node metastases? The Leuven
Lung Cancer Group.
Vansteenkiste JF, Stroobants SG, Dupont PJ, De Leyn PR, De Wever WF,
Verbeken EK, Nuyts JL, Maes FP, Bogaert JG.
Eur J Nucl Med (1998) 25(11):1495-1501.() |
Potential use of FDG-PET scan after
induction chemotherapy in surgically staged IIIa-N2 non-small-cell
lung cancer: a prospective pilot study. The Leuven Lung Cancer Group.
Vansteenkiste JF, Stroobants SG, De Leyn PR, Dupont PJ, Verbeken EK.
Ann Oncol (1998); 9(11):1193-1198.() |
TOP
Assessment of myocardial viability
in chronic coronary artery disease using technetium-99m Sestamibi
SPECT. Correlation with histology, positron emission tomography and
functional follow-up.
Maes A, Borgers M, Flameng W, Nuyts J, Van de Werf F, Ausma J, Sergeant
P, Mortelmans L.
J Amer Coll Cardiol (1997) 29:62-68.() |
Human brain activity related to orientation
discrimination tasks.
Orban G, Dupont P, Vogels R, Bormans G, Mortelmans L.
Eur J Neurosci (1997) 9:246-259.() |
Importance of flow/metabolism studies
in predicting late recovery of function following reperfusion in patients
with acute myocardial infarction.
Maes A, Mortelmans L, Bormans G, Herregods MC, Bijnens B, Van de Werf
F.
Eur Heart Journal (1997) 18:954-962.() |
Attention to one or two features in
left or right visual field: a PET study.
Vandenberghe R, Duncan J, Dupont P, Ward R, Poline JB, Bormans G,
Michiels J, Mortelmans L, Orban G.
J Neurosci (1997) 17:3739-3750.() |
The kinetic occipital area in human
visual cortex.
Dupont P, De Bruyn B, Vandenberghe R, Rosier A, Michiels J, Marchal
G, Mortelmans L, Orban G.
Cerebral cortex (1997) 7:283-292.() |
Positron-emission tomography imaging
of long-term shape recognition challenges.
Rosier A, Cornette L, Dupont P, Bormans G, Michiels J, Mortelmans
L, Orban G.
Proc Nat Acad Sci USA (1997) 94:7627-7632.()
|
Evaluation of carbon-11-labelled phenoxy
bridged fatty acids for studying myocardial fatty acid metabolism
with PET.
de Groot T, Maris B, Boonen C, Bormans G, Mortelmans L, Eisenhut M,
Verbruggen A.
Nucl Med Biol (1997) 24:461-464.() |
Noninvasive evaluation of lympho-venous
anastomosis in upper limb lymhedema.
Verlooy H, Biscompte JP, Nieuborg I, Drent P, Schiepers C, Mortelmans
L.
Eur J Lymphol Rel Probl (1997) 6:1-7.()
|
Mediastinal staging with FDG-PET-scan
in patients with potentially operable non-small cell lung cancer:
a prospective analysis of 50 cases.
Vansteenkiste J, Stroobants S, De Leyn P, Dupont P, Verschakelen J,
Nackaerts K, Mortelmans L , The Leuven Lung Cancer group.
Chest (1997) 112:1480-1486.() |
Fluoride kinetics of the axial skeleton
measured in vivo with Fluorine-18-Fluoride PET.
Schiepers C, Nuyts J, Bormans G, Dequeker J, Bouillon R, Mortelmans
L, Verbruggen A, De Roo M.
J Nucl Med (1997) 38(12):1970-1976.() |
Prediction of functional recovery
using PET-scan in patients undergoing coronary artery bypass grafting.
Flameng W, Shivalkar B, Spiessens B, Maes A, Nuyts J, Vanhaecke J,
Mortelmans L.
Ann Thorac Surg (1997) 64:1694-1701.() |
99Tcm-dimercaptopropionyl-HSA prepared
from a labelling kit: preliminary investigations as a blood pool agent.
Cambier JP, Verbeke KA, Vanbilloen HP, Bormans GM, de Roo MJ, Verbruggen
AM.
Nucl Med Commun (1997) 18(1):31-37.() |
Evaluation of carbon-11-labelled phenoxy
bridged fatty acids for studying myocardial fatty acid metabolism
with PET.
De Groot T, Maris B, Boonen C, Bormans G, Mortelmans L, Eisenhut M,
Verbruggen A.
Nucl Med Biol (1997) 24(5):461-464. |
Hibernating myocardium and the 'no
reflow' phenomenon: a study of absolute regional myocardial perfusion
and glucose metabolism using positron emission tomography in chronic
and acute heart disorders.
Maes A, Nuyts J.
Verh K Acad Geneeskd Belg (1997) 59(3):133-160.() |
Positron emission tomography, magnetic
resonance imaging and proton NMR spectroscopy of white matter in multiple
sclerosis.
Schiepers C, Van Hecke P, Vandenberghe R, Van Oostende S, Dupont P,
Demaerel P, Bormans G, Carton H.
Mult Scler (1997) 3(1):8-17.() |
Normal brain perfusion pattern of
technetium-99m-ethylcysteinate dimer in children.
Schiepers C, Verbruggen A, Casaer P, De Roo M.
J Nucl Med (1997) 38(7):1115-1120.() |
Size quantification of liver metastases
in patients undergoing cancer treatment: reproducibility of one-,
two-, and three-dimensional measurements determined with spiral CT.
Van Hoe L, Van Cutsem E, Vergote I, Baert AL, Bellon E, Dupont P,
Marchal G.
Radiology (1997) 202(3):671-675.() |
Effect of narcotic agents and of bleeding
on systemic and renal haemodynamics in healthy and CCl4-treated cirrhotic
rats.
Van Roey G, Lijnen P, Verbesselt R, Verbruggen A, Fevery J.
Clin Sci Lond (1997) 93(6):549-556.() |
Capillary electrophoretic analysis
of ethylene dicysteine, a precursor of the radiopharmaceutical 99mTc
ethylene dicysteine.
Van Schepdael A, Verbeke K, van Nerom C, Hoogmartens J, Verbruggen
A.
J Chromatogr B Biomed Sci Appl (1997) 697(1-2):251-254.() |
Usefulness of residual fractions of
L,L-ethylcysteinate dimer (Neurolite) for the preparation of 99Tc(m)-L,L-ethylcysteinate
dimer.
Verbeke K, Boonen C, Verbruggen A.
Nucl Med Commun (1997) 18(6):535-539.() |
Development and evaluation of a kit
formulation for the preparation of 99mTc-DMP-HSA, a new tracer agent
for radionuclide ventriculography.
Verbeke KA, Schiepers CW, Wyndaele DN, Baetens JA, Verbeke GN, de
Roo MJ, Verbruggen AM.
Nucl Med Biol (1997) 24(6):571-578.() |
Characteristics and biological behaviour
of 99mTc-labelled hydroxyacetyltriglycine, a potential alternative
to 99mTc-MAG3.
Vanbilloen HP, Dezutter NA, Cleynhens BJ, Verbruggen AM.
Eur J Nucl Med (1997) 24(11):1374-1379.() |
TOP
|
